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Recombinant, thermostable alpha-glucosidases from 
archaeal micro-organisms and isolated DNA encoding for 
Such alpha-glucosidases are provided. The isolated DNA is 
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the DNA encoding S. SulfataricuS alpha-glucosidase. Also 
provided are methods for producing recombinant archaeal 
thermostable alpha-glucosidase and transformants incorpo 
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plant tissue through the use of transgenic thermostable 
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HYPERTHERMOPHILIC ALPHA 
GLUCOSIDASE GENE AND ITS USE 
This application is related to U.S. provisional patent 
application Ser. No. 60/096,860, filed Aug. 18, 1998, incor 
porated herein by reference. 
BACKGROUND OF THE INVENTION 
The present invention relates to a novel nucleic acid 
coding for a thermostable glycosyl hydrolase, alpha 
glucosidase, from the archaeon SulfolobuS SolfataricuS and 
a novel enzyme coded by its gene, malA. It also relates to 
bacteria and plants transformed with hyperthermophilic 
alpha-glucosidase and a method for preparing the recombi 
nant alpha-glucosidase by use of the same. The present 
invention further relates to a method of using the transgenic 
thermostable glycosyl hydrolases for the bioprocessing of 
plant carbohydrates. 
The publications and other materials used herein to illu 
minate the background of the invention or provide additional 
details respecting the practice, are incorporated by reference, 
and for convenience are, in part, respectively grouped in the 
appended List of References. 
A variety of industries, Such as food and chemical, 
employ hydrolases for the production of glucose, Sucrose 
and other Sugars. High value is placed on thermoStability 
and thermoactivity of enzymes for use in the bioprocessing 
of Starch into maltodextrins, glucose, fructose and various 
other SugarS. 
One hydrolase, alpha-glucosidase, is defined by the Inter 
national Union of Biochemistry as an enzyme which hydro 
lyzes glucose oligomers to glucose. Alpha-glucosidase and 
other glycosidase genes from non-thermophilic eukaryotic 
and eubacterial organisms have been cloned and character 
ized (Hermans, et al., 1991). In addition, the major, 
endogenous, Soluble alpha-glucosidase from SulfolobuS Sol 
fataricuS has been purified and characterized. Although it 
has not, to date, been cloned, the native enzyme hydrolyzes 
Sucrose and liberates glucose from maltose. It has a tem 
perature optimum in excess of 100° C., with a prolonged half 
life at elevated temperatures, and is resistant to proteolysis 
and denaturants including chaotropes, detergents and ali 
phatic alcohols (Rolfsmeier and Blum, 1995). Another 
hydrolase from S. Solfataricus, beta-glycosidase, has been 
characterized (Haseltine, et al., 1999(a)). 
Plant-derived polysaccharides are used in enormous 
quantities as foods (Sugar) and, following conversion, in 
other Specialty and value added chemicals. Such as ethanol. 
Consequently, these materials are recognized as essential 
and are traded as commodities. Indeed, key measures of 
inflation are strongly influenced by the value assigned to 
Such commodities. Sugar (glucose) is produced by biopro 
cessing of plant Starch from plants including corn, Sugar 
beets and Sugar cane. Incremental improvements in Sugar 
production reflect two basic Strategies, increasing the yield 
of polysaccharide on a per plant mass basis and increasing 
the conversion of endogenous Starch into Sugar. Where the 
former approach results from advances in plant breeding, the 
latter approach initiated the introduction of microbial gene 
products as cell-free bioprocessing components. Key among 
these additives are two enzymes, alpha-amylase and gluco 
amylase, which are employed as commodity materials. 
Alpha-amylase is an endo-acting enzyme which debranches 
Starch yielding dextrin. Glucoamylase is an exo-acting 
enzyme which serially hydrolyzes dextrin subunits into free 
glucose. Plant Starch hydrolysis requires hydration to enable 
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enzyme action, consequently the introduction of water is a 
critical first Step and is conventionally performed by heating 
and extrusion. Cost effective bioprocessing necessitates 
rapid throughput therefore, a thermoStable alpha-amylase is 
commonly added to enable immediate debranching of 
hydrated starch. However, both the pH and the temperature 
of the bioprocessing reactors must thereafter be adjusted to 
create near-neutral and reduced temperatures to Support 
activity of the commercial glucoamylase. As a result, a 
Source of transgenic, thermostable glycosyl hydrolases 
would be an important contribution to the Starch processing 
industry due to their activity at high temperatures and 
eXtreme Stability at room temperatures, which offers 
extended Shelf life. Although glycosyl hydrolases occur 
among the hyperthermophillic archaea (Costantino, et al., 
1990; Rolfsmeirand Blum, 1995; Haseltine, et al., 1999(a)), 
their culture as a Source of enzyme is complicated by their 
extreme growth requirements. Furthermore, expression of 
archaeal enzymes in heterologous hosts is complicated by 
the altered environment in which expression occurs and 
difficulty with translation and post translational processing 
(Trent, et al., 1991). Over production of archaeal proteins in 
plants would require that the protein fold properly in plants 
which, for thermostable proteins, may require chaperones 
not normally present in plants. To date, no archaeal alpha 
glucosidase genes have been cloned or expressed recombi 
nantly. 
SUMMARY OF THE INVENTION 
The present invention relates to a novel nucleic acid 
coding for a thermostable glycosyl hydrolase, alpha 
glucosidase, from the archaeon SulfolobuS SolfatoricuS and 
a novel enzyme coded by its gene, malA. It also relates to 
bacteria and plants transformed with hyperthermophilic 
alpha-glucosidase and a method for preparing the recombi 
nant alpha-glucosidase by use of the Same. The present 
invention further relates to a method of using the transgenic 
thermostable glycosyl hydrolases for the bioprocessing of 
plant carbohydrates. 
The malA gene of the present invention has been 
identified, cloned and expressed in bacteria and plants. The 
distribution and associated activity of the malA gene in the 
three most common members of the Sulfolobus genus have 
been determined. 
The purified alpha-glucosidase produced by the recom 
binant malA gene, provides an extremely thermostable 
enzyme which is able to hydrolyze a Surprisingly wide range 
of polysaccharides to glucose. Substrates include Starch and 
maltodextrins indicating that the enzyme acts as both an 
alpha-amylase and an alpha-glucosidase. Additionally, 
Sucrose is hydrolyzed to invert Sugar by the malA gene 
product, indicating the enzyme is also a Sucrase. 
Extracts of transgenic plants of the present invention 
expressing thermostable glycosyl hydrolases have been pre 
pared. The plant extracts are able to undergo “autohydroly 
Sis' of plant polysaccharide into glucose and other SugarS. 
The recombinant glycosyl hydrolases expressed in the trans 
genic plants are nontoxic in plant tissues because the 
enzymes are inactive at temperatures Supporting plant 
growth and therefore do not significantly interfere with 
normal metabolism in the living plant. Thus, regulated plant 
promoters are not required and constitutive promoters are 
Sufficient. When desired, the transgenic plant tissue can be 
heated to activate the enzymes, causing in Situ processing of 
Storage carbohydrates to glucose and other Small molecules 
by the recombinant plant extract, itself. This obviates the 
US 6,506,592 B1 
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need to add Separately produced commodity enzymes to 
plant material, as is the current method used in industry. 
Accordingly, this invention comprises the following 
aspects: 
1) An isolated nucleic acid molecule encoding thermo 
Stable alpha-glucosidase comprising the nucleotide 
sequence of SEQ ID NO:1. 
2) An expression vector comprising the nucleotide 
sequence of SEQ ID NO: 1. 
3) Transformed host cells comprising the nucleotide 
sequence of SEQ ID NO: 1. 
4) Transformed host cells expressing the recombinant 
amino acid sequence of SEQ ID NO:2. 
5) Methods of preparing the transformed hosts of 4). 
6) Methods for extracting and purifying heterologous, 
thermostable glycosyl hydrolases from transformed 
host cells. 
7) Characterization of recombinant glycosyl hydrolase 
enzymes, including their useful chemical and physical 
properties and utility for industrial applications. 
8) Novel recombinant enzyme of 7) comprising the amino 
acid sequence of SEQ ID NO:2. 
9) Transgenic plant cells expressing thermostable glyco 
Syl hydrolases that are capable of autohydrolysis (in 
Situ processing) of Substrate into glucose and other 
Small molecules. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIGS. 1A and 1B are the malA coding region and a gene 
construct containing the malA gene from Sulfolobus Solfa 
taricus. The malA coding sequence plus 30 bp of the malA 
promoter region was cloned into the Xho I/Bam HI site of 
the plant expression vector pRTL2 between the enhanced 
35S promoter and the 35S polyadenylation signal. The 3.5 
kb Pst I fragment of the resulting plasmid was then cloned 
into the multiple cloning site of the binary vector pPZP112 
to produce the construct pPB709 for transformation into 
plants. 
FIGS. 2A and 2B show the DNA sequence (SEQ ID 
NO:1) and deduced, encoded amino acid sequence (SEQ ID 
NO:2) of the malA gene. 
FIGS. 3A and 3B show the distribution of malA DNA 
among Sulfolobus species as determined by Southern blot. 
FIGS. 4A and 4B show the pH optima of recombinant 
alpha-glucosidase for maltose and glycogen hydrolysis. 
FIGS. 5A and 5B show levels of thermostable glycosyl 
hydrolases in transgenic tobacco transformants. FIG. 5A 
ShowS levels of alpha-glucosidase activity in independent 
transformed plants. FIG. 5B shows levels of beta 
glycosidase activity in independent transformed plants. 
FIG. 6 shows a densitometry tracing of a western blot of 
malA plant extract and purified alpha-glucosidase. 
FIGS. 7A and B show the release of glucose by transgenic 
glycosyl hydrolases from exogenous and endogenous plant 
carbohydrates. FIG. 7A. Glucose released by the alpha 
glucosidase using an exogenous Soluble Starch as Substrate. 
A 5% (w/v) solution of soluble starch was incubated at 80° 
C. with no additions (closed circles), with a protein extract 
from a plant transformed with an empty vector (open circles) 
and with a protein extract from transformant MI52E con 
taining the alpha-glucosidase (closed Squares). FIG. 7B. 
Glucose released by glycosyl hydrolases using an endog 
enous polysaccharide-enriched plant extract as Substrate. 
Protein extracts were: beta-glycosidase (closed Squares), 
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alpha-glucosidase (closed circles), and empty vector trans 
formed plant (labeled). Glucose levels were determined 
using the glucose oxidase assay. 
FIGS. 8A, 8B and 8C are plots of recombinant alpha 
glucosidase activity and protein content per milligram fresh 
weight in leaves of T2 tobacco plants at 70, 95 and 116 days 
after Seeding, respectively. 
FIGS. 9A and 9B. 9A shows the bacterial expression 
vector including the malA gene.9B is a Northern blot of the 
malA region of the vector. 
FIGS. 10A and 10B. 10A shows the plant expression 
plasmid including the malA gene. 10B is a Northern blot of 
the malA region of the plasmid. 
FIGS. 11A and 11B show accumulation of recombinant 
glycosyl hydrolase activities in aging transgenic tobacco 
plants. FIG. 11A shows levels of alpha-glucosidase. Mean 
enzyme specific activities representing Samples from five 
leaves (closed circles) were determined from the same plant 
at the indicated times after plant Seeding. Total leaf protein 
(open circles) was determined per leaf area. FIG. 11B shows 
levels of beta-glycosidase. 
FIGS. 12A, 12B and 12C show the presence of glycosyl 
hydrolases in transformed tobacco leaves. FIG. 12A shows 
a colormetric western blot analysis of alpha-glucosidase in 
transgenic plant leaves. Lane 1, E. coli-derived recombinant 
alpha-glucosidase; lane 2, protein extract of transformant 
MI52E.; lane 3, protein extract of plant transformed with an 
empty vector. Samples for western blots were loaded in 20 
tug amounts per lane. Blots were probed with rabbit anti 
beta-glycosidase polyclonal antibodies. FIG. 12B shows a 
colormetric Western blot analysis of beta-glycosidase in 
plant leaves. Lane 1, protein extract of transformant JJ-6; 
lane 2, protein extract of plant transformed with an empty 
vector, lane 3, extract of E. coli containing puC19, lane 4, 
E. coli-derived recombinant beta-glycosidase. FIG. 12C. 
Immunoprecipitation of alpha-glucosidase activity from 
transformant MI52E. 
SUMMARY OF SEQUENCE LISTING 
SEQ ID NO:1 is the nucleotide sequence for the malA 
gene. SEQID NO:2 is the amino acid sequence for the malA 
protein. SEQ ID NO:3 is the N-terminal amino acid 
Sequence for alpha-glucosidase from S. Sulfataricus. SEQID 
NO:4 is the amino acid Sequence for alpha-glucosidase 
generated by chemical cleavage with cyanogen bromide. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The present invention relates to a novel nucleic acid 
coding for a thermostable glycosyl hydrolase, alpha 
glucosidase, from the archaeon SulfolobuS SolfatoricuS and 
a novel enzyme coded by its gene, malA. It also relates to 
bacteria and plants transformed with hyperthermophilic 
alpha-glucosidase and a method for preparing the recombi 
nant alpha-glucosidase by use of the Same. The present 
invention further relates to a method of using the transgenic 
thermostable glycosyl hydrolases for the bioprocessing of 
plant carbohydrates. 
Cloning, Characterization and Expression of malA Gene 
Using gene-Specific PCR primerS derived from the alpha 
glucosidase protein Sequence as probe to Screen a genomic 
S. Solfataricus 98/2 phage lambda library, the malA gene of 
the present invention has been cloned and characterized 
(GenBank Accession No. AF042494). The nucleotide 
sequence is set forth as SEQ ID NO:1 (FIG. 2), and the 
US 6,506,592 B1 
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amino acid sequence is set forth as SEQ ID NO:2 (FIG. 2). 
It has been found that the malA sequence comprises 2,083 
bp encoding a protein of 693 amino acids. 
In carrying out this invention, isolation and purification of 
DNA carrying the genetic information of the thermostable 
glycosyl hydrolases from Sulfolobus Solfataricus was per 
formed by conventional means. For instance, restriction 
digestion and ligation of DNA and DNA sequence analysis 
were performed as described previously. (Blum, et al., 1992; 
Rockabrand and Blum, 1995; Haseltine, et al., (1999(a)). 
Insertion of chromosomal DNA into vector DNA was 
performed by digesting the chromosomal DNA and plasmid 
DNA with restriction enzymes to yield chromosomal DNA 
and plasmid DNA fragments and treating the mixture of 
those with DNA ligases. 
The resulting plasmids were introduced into a bacterial 
host and/or used to transform Agrobacterium tumefacienS by 
freeze-thaw method (An, et al., 1988). The transformed A. 
tumefacienS was used to transform plants by the leaf disc 
method of Horsch, et al., 1985. All manipulations of 
Escherichia coli were as described previously in 
Rockabrand, et al., 1995. 
The production of the recombinant enzymes of this inven 
tion were conducted by over expression in E. coli. ASSayS 
for alpha-glucosidase activity were performed with para 
nitrophe nyl-alpha-D-glucopy rano Side O 
methylumbelliferyl-alpha-D-glucoside. Assays for hydroly 
sis of Substrate and detection of glucose were monitored by 
means known in the art. Purification of the recombinant 
enzyme to apparent homogeneity employed heat fraction 
ation of clarified cell Sonicates followed by anion-exchange 
fast protein liquid chromatography and gel filtration fast 
protein liquid chromatography as described in Rolfsmeier, et 
al., 1995. 
Autodigestion of Plant Tissue. Using Hyperthermophilic 
Glycosyl Hydrolases 
New Strategies to accomplish improved plant bioprocess 
ing rest on the merging technology of plant metabolic 
engineering (Sommerville and Sommerville, 1999). Meta 
bolic engineering of plant biochemistry includes an expand 
ing list of Secondary metabolites and modified pathway end 
products ranging from lipids to Small molecules. Balanced 
against this goal are the physiological consequences result 
ing from the accumulation of foreign, and possibly toxic, 
compounds. Clearly improvements in bioprocessing will 
lead to further improvements in agricultural proceSS eco 
nomics and create new opportunities to increase the types 
and amounts of derivative materials. One approach for 
improving bioprocessing is to eliminate the need to add 
commodity enzymes for starch hydrolysis. To fit the current 
technology, however, this necessitates the use of thermotol 
erant catalysts. In addition, other plant polysaccharides Such 
as beta-linked polymeric Sugars are not currently used in 
commercial processes. 
Archaea have recently been recognized as a distinct 
branch of prokaryotes, as distantly related to bacteria as they 
are to eukaryotic organisms. (Woese, et al., 1990; Whitman, 
et al., 1999). They include three dominant biotypes; the 
hyperthermophiles, the methanogens and the halophiles, 
each is associated with distinct and extreme environments. 
The present invention relates to the hyperthermophiles 
which produce numerous proteins of industrial interest 
(Cowan, 1992). Key among these activities are those which 
promote the hydrolysis of plant polysaccharides (Sunna, 
1997). Several representative activities from the hyperther 
mophile SulfolbOuS SOlfataricus, are characterized herein at 
both the genetic and functional level. S. SolfataricuS Secretes 
15 
25 
35 
40 
45 
50 
55 
60 
65 
6 
an acid-resistant thermotolerant alpha-amylase (amy A) 
which retains full function after one week of 80 C. at pH 3 
(Haseltine, et al., 1996; Haseltine, et al., 1999(a)). Two other 
activities have been characterized: a) a cell associated alpha 
glucosidase or alpha-glucosidase (malA) with a temperature 
optimum of 105 C. which converts dextrins and other 
alpha-linked polymers into glucose (Rolfsmeier and Blum, 
1995), and b) a beta-glycosidase (lacs) which converts 
beta-linked disaccharides into glucose (Haseltine, et al., 
1999(b)). Both the alpha-glucosidase and the beta 
glycosidase have been Surprisingly discovered to have broad 
Substrate preferences. It has been unexpectedly determined 
the transgenic plants expressing these last two activities are 
able, upon heating at elevated temperatures, to undergo a 
process of autodigestion converting polysaccharides into 
monosaccharides in a Single Step. 
Definitions 
The present invention employs the following definitions. 
AS used herein, “autodigestion' and “autohydrolysis” is 
the ability of transgenic plant tissue which encodes for and 
expresses heterologous thermostable glycosyl hydrolase to 
undergo hydrolysis of Substrate into glucose and other Small 
molecules when Subjected to heat. 
AS used herein, “alpha-glycosidase' refers to an enzyme 
which Splits polysaccharides, through the hydrolysis of 
glycosidic bonds. 
“Encode”. A polynucleotide is said to “encode” a 
polypeptide if, in its native State or when manipulated by 
methods well known to those skilled in the art, it can be 
transcribed and/or translated to produce the mRNA for 
and/or the polypeptide or a fragment thereof. The anti-Sense 
Strand is the complement of Such a nucleic acid, and the 
encoding Sequence can be deduced therefrom. 
As used herein, “expression system” refers to DNA 
Sequences containing a desired coding Sequence and control 
Sequences in operable linkage, So that hosts transformed 
with these Sequences are capable of producing the encoded 
proteins. In order to effect transformation, the expression 
System may be included on a vector, however, the expression 
System may then also be integrated into the host chromo 
SOC. 
AS used herein, “gene’ refers to a DNA sequence that 
encodes a recoverable bioactive polypeptide or precursor. 
The polypeptide can be encoded by a full-length gene 
Sequence or any portion of the coding Sequence So long as 
the enzyme activity is maintained. 
AS used herein, “glycosyl hydrolase' refers to enzymes 
which hydrolyze substances linked by glycosyl bonds, for 
example, polysaccharides. 
AS used herein, "hyperthermophilic' refers to an organ 
ism capable of growth above 70 degrees C., or proteins 
derived from Such an organism. 
“Isolated” or “substantially pure”. An "isolated” or “sub 
Stantially pure' nucleic acid (e.g., an RNA, DNA or a mixed 
polymer) or protein is one which is Substantially separated 
from other cellular components which naturally accompany 
a native Sequence or protein, e.g., ribosomes, polymerases, 
many other Sequences and proteins. The term embraces a 
nucleic acid Sequence or protein which has been removed 
from its naturally occurring environment, and includes 
recombinant or cloned DNA isolates and chemically syn 
thesized analogs or analogs biologically Synthesized by 
heterologous Systems. 
“malA Allele” refers to normal alleles of the malA gene. 
“malA Locus”, “malA Gene”, “malA Nucleic Acids” or 
“malA Polynucleotide” each refer to polynucleotides, all of 
which are in the malA region, that are likely to be expressed 
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in normal tissue. The malA locus is intended to include 
coding Sequences, intervening Sequences and regulatory 
elements controlling transcription and/or translation. The 
malA locus is intended to include all allelic variations of the 
DNA sequence. 
These terms, when applied to a nucleic acid, refer to a 
nucleic acid which encodes an archaeal malA polypeptide, 
fragment, homolog or Variant, including, e.g., protein 
fusions or deletions. The nucleic acids of the present inven 
tion will possess a Sequence which is either derived from, or 
Substantially Similar to a natural malA-encoding gene or one 
having Substantial homology with a natural malA-encoding 
gene or a portion thereof. 
The malA gene or nucleic acid includes normal alleles of 
the malA gene, including Silent alleles having no effect on 
the amino acid Sequence of the malA polypeptide as well as 
alleles leading to amino acid Sequence variants of the malA 
polypeptide that do not Substantially affect its function. 
These terms also include alleles having one or more muta 
tions which adversely affect the function of the malA 
polypeptide. A mutation may be a change in the malA 
nucleic acid Sequence which produces a deleterious change 
in the amino acid Sequence of the malA polypeptide, result 
ing in partial or complete loSS of malA function, or may be 
a change in the nucleic acid Sequence which results in the 
loSS of effective malA expression or the production of 
aberrant forms of the malA polypeptide. 
The malA nucleic acid may be that shown in SEQ ID 
NO:1 or it may be an allele as described above or a variant 
or derivative differing from that shown by a change which 
is one or more of addition, insertion, deletion and Substitu 
tion of one or more nucleotides of the Sequence shown. 
Changes to the nucleotide Sequence may result in an amino 
acid change at the protein level, or not, as determined by the 
genetic code. 
Thus nucleic acids according to the present invention may 
include a Sequence different from the Sequence shown in 
SEQ ID NO:1 yet encode a polypeptide with..the same amino 
acid sequence as shown in SEQ ID NO:2. That is, nucleic 
acids of the present invention include Sequences which are 
degenerate as a result of the genetic code. On the other hand, 
the encoded polypeptide may comprise an amino acid 
Sequence which differs by one or more amino acid residues 
from the amino acid sequence shown in SEQ ID NO:2. 
Nucleic acid encoding a polypeptide which is an amino acid 
Sequence variant, derivative or allele of the amino acid 
sequence shown in SEQ ID NO:2 is also provided by the 
present invention. 
The malA gene also refers to (a) any DNA sequence that 
(i) hybridizes to the complement of the DNA sequences that 
encode the amino acid sequence set forth in SEQ ID NO:2 
under highly stringent conditions (Ausubel, et al., 1992) and (ii) encodes a gene product functionally equivalent to malA, 
or (b) any DNA sequence that (i) hybridizes to the comple 
ment of the DNA sequences that encode the amino acid 
sequence set forth in SEQ ID NO:2 under less stringent 
conditions, Such as moderately Stringent conditions 
(Ausubel, et al., 1992) and (ii) encodes a gene product 
functionally equivalent to malA. The invention also includes 
nucleic acid molecules that are the complements of the 
Sequences described herein. 
The polynucleotide compositions of this invention 
include RNA, cDNA, genomic DNA, synthetic forms, and 
mixed polymers, both Sense and antisense Strands, and may 
be chemically or biochemically modified or may contain 
non-natural or derivatized nucleotide bases, as will be 
readily appreciated by those skilled in the art. Such modi 
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fications include, for example, labels, methylation, Substi 
tution of one or more of the naturally occurring nucleotides 
with an analog, internucleotide modifications Such as 
uncharged linkages (e.g., methyl phosphonates, 
phosphotriesters, phosphoramidates, carbamates, etc.), 
charged linkage S (e.g., phosphor othioate S, 
phosphorodithioates, etc.), pendent moieties (e.g., 
polypeptides), intercalators (e.g., acridine, psoralen, etc.), 
chelators, alkylators, and modified linkages (e.g., alpha 
anomeric nucleic acids, etc.). Also included are synthetic 
molecules that mimic polynucleotides in their ability to bind 
to a designated Sequence via hydrogen bonding and other 
chemical interactions. Such molecules are known in the art 
and include, for example, those in which peptide linkages 
Substitute for phosphate linkages in the backbone of the 
molecule. 
The present invention provides recombinant nucleic acids 
comprising all or part of the malA region. The recombinant 
construct may be capable of replicating autonomously in a 
host cell. Alternatively, the recombinant construct may 
become integrated into the chromosomal DNA of the host 
cell. Such a recombinant polynucleotide comprises a poly 
nucleotide of genomic, cDNA, Semi-Synthetic, or Synthetic 
origin which, by virtue of its origin or manipulation, 1) is not 
asSociated with all or a portion of a polynucleotide with 
which it is associated in nature; 2) is linked to a polynucle 
otide other than that to which it is linked in nature; or 3) does 
not occur in nature. Where nucleic acid according to the 
invention includes RNA, reference to the Sequence shown 
should be construed as reference to the RNA equivalent, 
with USubstituted for T. 
Therefore, recombinant nucleic acids comprising 
Sequences otherwise not naturally occurring are provided by 
this invention. Although the wild-type Sequence may be 
employed, it will often be altered, e.g., by deletion, Substi 
tution or insertion. cDNA or genomic libraries of various 
types may be Screened as natural Sources of the nucleic acids 
of the present invention, or Such nucleic acids may be 
provided by amplification of Sequences resident in genomic 
DNA or other natural sources, e.g., by PCR. The choice of 
cDNA libraries normally corresponds to a tissue Source 
which is abundant in mRNA for the desired proteins. Phage 
libraries are normally preferred, but other types of libraries 
may be used. Clones of a library are spread onto plates, 
transferred to a Substrate for Screening, denatured and 
probed for the presence of desired Sequences. 
The DNA sequences used in this invention will usually 
comprise at least about five codons (15 nucleotides), more 
usually at least about 7-15 codons, and most preferably, at 
least about 35 codons. This number of nucleotides is usually 
about the minimal length required for a Successful probe that 
would hybridize Specifically with an malA-encoding 
Sequence. In this context, oligomers of as low as 8 
nucleotides, more generally 8-17 nucleotides, can be used 
for probes, especially in connection with chip technology. 
Techniques for nucleic acid manipulation are described 
generally, for example, in Sambrook, et al., 1989 or Ausubel, 
et al., 1992. Reagents useful in applying Such techniques, 
Such as restriction enzymes and the like, are widely known 
in the art and commercially available from Such vendors as 
New England BioLabs, Boehringer Mannheim, Amersham, 
Promega, U.S. Biochemicals, New England Nuclear, and a 
number of other Sources. The recombinant nucleic acid 
Sequences used to produce fusion proteins of the present 
invention may be derived from natural or Synthetic 
Sequences. Many natural gene Sequences are obtainable 
from various cDNA or from genomic libraries using appro 
priate probes. See, GenBank, National Institutes of Health. 
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AS used herein, “operably linked” refers to a juxtaposition 
wherein the components So described are in a relationship 
permitting them to function in their intended manner. For 
example, a promoter is linked to a coding Sequence if the 
promoter affects its transcription or expression. 
AS used herein, a "portion' of the malA locus or region or 
allele is defined as having a minimal size of at least about 
eight nucleotides, or preferably about 15 nucleotides, or 
more preferably at least about 21 nucleotides, and may have 
a minimal size of at least about 40 nucleotides. This defi 
nition includes all sizes in the range of 8–40 nucleotides as 
well as greater than 40 nucleotides. Thus, this definition 
includes nucleic acids of 8, 12, 15, 20, 25, 40, 60, 80, 100, 
200, 300, 400, 500 nucleotides, or nucleic acids having any 
number of nucleotides within these ranges of values (e.g., 9, 
10, 11, 16, 23, 30, 38, 50, 72, 121, etc., nucleotides), or 
nucleic acids having more than 500 nucleotides, or any 
number of nucleotides between 500 and the number shown 
in SEQ ID NO:1. The present invention includes all novel 
nucleic acids having at least 8 nucleotides derived from SEQ 
ID NO:1, its complement or functionally equivalent nucleic 
acid Sequences. The present invention does not include 
nucleic acids which exist in the prior art. That is, the present 
invention includes all nucleic acids having at least 8 nucle 
otides derived from SEQ ID NO:1 with the proviso that it 
does not include nucleic acids existing in the prior art. 
“malA protein' or “malA polypeptide” refers to a protein 
or polypeptide encoded by the malA locus, variants or 
fragments thereof. The term “polypeptide' refers to a poly 
mer of amino acids and its equivalent and does not refer to 
a Specific length of the product; thus, peptides, oligopeptides 
and proteins are included within the definition of a polypep 
tide. This term also does not refer to, or exclude modifica 
tions of the polypeptide, for example, glycosylations, 
acetylations, phosphorylations, and the like. Included within 
the definition are, for example, polypeptides containing one 
or more analogs of an amino acid (including, for example, 
unnatural amino acids, etc.), polypeptides with Substituted 
linkages as well as other modifications known in the art, 
both naturally and non-naturally occurring. Ordinarily, Such 
polypeptides will be at least about 50% homologous to the 
native malA sequence, preferably in excess of about 90%, 
and more preferably at least about 95% homologous. Also 
included are proteins encoded by DNA which hybridizes 
under high or low Stringency conditions, to malA-encoding 
nucleic acids and closely related polypeptides or proteins 
retrieved by antisera to the malA protein(s). 
The malA polypeptide may be that shown in SEQ ID 
NO:2 which may be in isolated and/or purified form, free or 
substantially free of material with which it is naturally 
asSociated. The polypeptide may, if produced by expression 
in a prokaryotic cell or produced Synthetically, lack native 
post-translational processing, Such as glycosylation. 
Alternatively, the present invention is also directed to 
polypeptides which are Sequence variants, alleles or deriva 
tives of the malA polypeptide. Such polypeptides may have 
an amino acid Sequence which differs from that Set forth in 
SEQ ID NO:2 by one or more of addition, Substitution, 
deletion or insertion of one or more amino acids, provided 
Such polypeptides have malA function. 
Substitutional variants typically contain the exchange of 
one amino acid for another at one or more Sites within the 
protein, and may be designed to modulate one or more 
properties of the polypeptide, Such as Stability against pro 
teolytic cleavage, without the loSS of other functions or 
properties. Amino acid Substitutions may be made on the 
basis of Similarity in polarity, charge, Solubility, 
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hydrophobicity, hydrophilicity, and/or the amphipathic 
nature of the residues involved. Preferred Substitutions are 
ones which are conservative, that is, one amino acid is 
replaced with one of Similar shape and charge. Conservative 
Substitutions are well known in the art and typically include 
Substitutions within the following groups: glycine, alanine; 
Valine, isoleucine, leucine; aspartic acid, glutamic acid; 
asparagine, glutamine, Serine, threonine; lysine, arginine; 
and tyrosine, phenylalanine. 
Certain amino acids may be Substituted for other amino 
acids in a protein Structure without appreciable loSS of 
interactive binding capacity with Structures Such as, for 
example, antigen-binding regions of antibodies or binding 
Sites on Substrate molecules or binding Sites on proteins 
interacting with the malA polypeptide. Since it is the inter 
active capacity and nature of a protein which defines that 
protein's biological functional activity, certain amino acid 
Substitutions can be made in a protein Sequence, and its 
underlying DNA coding Sequence, and nevertheless obtain a 
protein with like properties. In making Such changes, the 
hydropathic index of amino acid Side chains may be con 
sidered. The importance of the hydropathic amino acid index 
in conferring interactive biological function on a protein is 
generally understood in the art (Kyte and Doolittle, 1982). 
Alternatively, the Substitution of like amino acids can be 
made effectively on the basis of hydrophilicity. The impor 
tance of hydrophilicity in conferring interactive biological 
function of a protein is generally understood in the art (U.S. 
Pat. No. 4,554,101). The use of the hydrophobic index or 
hydrophilicity in designing polypeptides is further discussed 
in U.S. Pat. No. 5,691,198. 
The length of polypeptide Sequences compared for 
homology will generally be at least about 16 amino acids, 
usually at least about 20 residues, more usually at least about 
24 residues, typically at least about 28 residues, and pref 
erably more than about 35 residues. 
“Probes”. Polynucleotide sequences associated with malA 
or lacS alleles are detected by hybridization with a poly 
nucleotide probe which forms a stable hybrid with that of the 
target Sequence, under highly Stringent to moderately Strin 
gent hybridization and wash conditions. If it is expected that 
the probes will be perfectly complementary to the target 
Sequence, high Stringency conditions will be used. Hybrid 
ization Stringency may be lessened if Some mismatching is 
expected, for example, if variants are expected with the 
result that the probe will not be completely complementary. 
Conditions are chosen which rule out nonspecific/ 
adventitious bindings, that is, which minimize noise. (It 
should be noted that throughout this disclosure, if it is 
Simply Stated that “stringent conditions are used that is 
meant to be read as “high Stringency conditions are used.) 
Since such indications identify neutral DNA polymorphisms 
as well as mutations, these indications need further analysis 
to demonstrate detection of an malA or lacS Susceptibility 
allele. 
Probes for malA or lacS alleles may be derived from the 
Sequences of the respective region, its cDNA, functionally 
equivalent Sequences, or the complements thereof. The 
probes may be of any Suitable length, which span all or a 
portion of the respective region, and which allow specific 
hybridization to the region. If the target Sequence contains a 
Sequence identical to that of the probe, the probes may be 
Short, e.g., in the range of about 8-30 base pairs, Since the 
hybrid will be relatively stable under even highly stringent 
conditions. If Some degree of mismatch is expected with the 
probe, i.e., if it is suspected that the probe will hybridize to 
a variant region, a longer probe may be employed which 
hybridizes to the target Sequence with the requisite Speci 
ficity. 
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The probes will include an isolated polynucleotide 
attached to a label or reporter molecule and may be used to 
isolate other polynucleotide Sequences, having Sequence 
Similarity by Standard methods. For techniques for preparing 
and labeling probes See, e.g., Sambrook et al., 1989 or 
Ausubel et al., 1992. Other similar polynucleotides may be 
Selected by using homologous polynucleotide S. 
Alternatively, polynucleotides encoding these or Similar 
polypeptides may be Synthesized or Selected by use of the 
redundancy in the genetic code. Various codon Substitutions 
may be introduced, e.g., by Silent changes (thereby produc 
ing various restriction sites) or to optimize expression for a 
particular System. Mutations may be introduced to modify 
the properties of the polypeptide, perhaps to change the 
polypeptide degradation or turnover rate. 
Probes comprising Synthetic oligonucleotides or other 
polynucleotides of the present invention may be derived 
from naturally occurring or recombinant Single- or double 
Stranded polynucleotides, or be chemically Synthesized. 
Probes may also be labeled by nick translation, Klenow 
fill-in reaction, or other methods known in the art. 
Portions of the polynucleotide Sequence having at least 
about eight nucleotides, usually at least about 15 
nucleotides, and fewer than about 9 kb, usually fewer than 
about 1.0 kb, from a polynucleotide Sequence encoding 
malA are preferred as probes. This definition therefore 
includes probes of sizes 8 nucleotides through 9000 nucle 
otides. Thus, this definition includes probes of 8, 12, 15, 20, 
25, 40, 60, 80, 100, 200, 300, 400 or 500 nucleotides or 
probes having any number of nucleotides within these 
ranges of values (e.g., 9, 10, 11, 16, 23, 30, 38, 50, 72, 121, 
etc., nucleotides), or probes having more than 500 
nucleotides, or any number of nucleotides between 500 and 
the number of nucleotides in SEQID NO:1. The probes may 
also be used to determine whether mRNA encoding malA is 
present in a cell or tissue. The present invention includes all 
novel probes having at least 8 nucleotides derived from SEQ 
ID NO:1, its complement or functionally equivalent nucleic 
acid Sequences. The present invention does not include 
probes which exist in the prior art. That is, the present 
invention includes all probes having at least 8 nucleotides 
derived from SEQID NO:1 with the proviso that they do not 
include probes existing in the prior art. 
Similar considerations and nucleotide lengths are also 
applicable to primers which may be used for the amplifica 
tion of all or part of the malA gene. Thus, a definition for 
primers includes primers of 8, 12, 15, 20, 25, 40, 60,80, 100, 
200, 300, 400, 500 nucleotides, or primers having any 
number of nucleotides within these ranges of values (e.g., 9, 
10, 11, 16, 23, 30, 38, 50, 72, 121, etc. nucleotides), or 
primerS having more than 500 nucleotides, or any number of 
nucleotides between 500 and 9000. The primers may also be 
used to determine whether mRNA encoding malA is present 
in a cell or tissue. The present invention includes all novel 
primerS having at least 8 nucleotides derived from the malA 
locus for amplifying the malA gene, its complement or 
functionally equivalent nucleic acid Sequences. The present 
invention does not include primers which exist in the prior 
art. That is, the present invention includes all primerS having 
at least 8 nucleotides with the proviso that it does not include 
primers existing in the prior art. 
“Protein modifications or fragments” are provided by the 
present invention for malA polypeptides or fragments 
thereof which are Substantially homologous to primary 
Structural Sequence but which include, e.g., in Vivo or in 
vitro chemical and biochemical modifications or which 
incorporate unusual amino acids. Such modifications 
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include, for example, acetylation, carboxylation, 
phosphorylation, glycosylation, ubiquitination, labeling, 
e.g., with radionuclides, and Various enzymatic 
modifications, as will be readily appreciated by those well 
skilled in the art. A variety of methods for labeling polypep 
tides and of Substituents or labels useful for Such purposes 
are well known in the art, and include radioactive isotopes 
Such as P, ligands which bind to labeled antiligands (e.g., 
antibodies), fluorophores, chemiluminescent agents, 
enzymes, and antiligands which can Serve as Specific bind 
ing pair members for a labeled ligand. The choice of label 
depends on the Sensitivity required, ease of conjugation with 
the primer, Stability requirements, and available instrumen 
tation. Methods of labeling polypeptides are well known in 
the art. See Sambrook et al., 1989 or Ausubel et al., 1992. 
Besides Substantially full-length polypeptides, the present 
invention provides for biologically active fragments of the 
polypeptides. Significant biological activities include 
ligand-binding, enzymatic activity and other biological 
activities characteristic of malA polypeptides. 
The present invention also provides for fusion 
polypeptides, comprising malA polypeptides and fragments. 
Homologous polypeptides may be fusions between two or 
more malA polypeptide Sequences or between the Sequences 
of malA and a related protein. Likewise, heterologous 
fusions may be constructed which would exhibit a combi 
nation of properties or activities of the derivative proteins. 
For example, ligand-binding or other domains may be 
“swapped” between different new fusion polypeptides or 
fragments. Such homologous or heterologous fusion 
polypeptides may display, for example, altered Strength or 
Specificity of binding. Fusion partners include 
immunoglobulins, bacterial f-galactosidase, trpE, protein A, 
f-lactamase, alpha amylase, alcohol dehydrogenase and 
yeast alpha mating factor. See Godowski et al., 1988. 
Fusion proteins will typically be made by either recom 
binant nucleic acid methods, as described below, or may be 
chemically Synthesized. Techniques for the Synthesis of 
polypeptides are described, for example, in Merrifield, 1963. 
“Protein purification', unless otherwise specifically 
described or incorporated herein, refers to various methods 
for the isolation of the malA and lacS polypeptides from 
other biological material, Such as from cells transformed 
with recombinant nucleic acids encoding malA or lacS, and 
are well known in the art. For example, Such polypeptides 
may be purified by immunoaffinity chromatography 
employing, e.g., the antibodies provided by the present 
invention. Various methods of protein purification are well 
known in the art, and include those described in Deutscher, 
1990 and Scopes, 1982. 
The terms “isolated”, “substantially pure”, and “substan 
tially homogeneous” are used interchangeably to describe a 
protein or polypeptide which has been Separated from com 
ponents which accompany it in its natural State. A mono 
meric protein is Substantially pure when at least about 60 to 
75% of a Sample exhibits a Single polypeptide Sequence. A 
Substantially pure protein will typically comprise about 60 to 
90% w/w of a protein sample, more usually about 95%, and 
preferably will be over about 99% pure. Protein purity or 
homogeneity may be indicated by a number of means well 
known in the art, Such as polyacrylamide gel electrophoresis 
of a protein Sample, followed by Visualizing a single 
polypeptide band upon Staining the gel. For certain 
purposes, higher resolution may be provided by using HPLC 
or other means well known in the art which are utilized for 
purification. 
malA and lacS proteins are Substantially free of naturally 
asSociated components when they are separated from the 
US 6,506,592 B1 
13 
native contaminants which accompany them in their natural 
State. Thus, a polypeptide which is chemically Synthesized 
or synthesized in a cellular system different from the cell 
from which it naturally originates will be substantially free 
from its naturally associated components. A protein may 
also be rendered Substantially free of naturally associated 
components by isolation, using protein purification tech 
niques well known in the art. 
A polypeptide produced as an expression product of an 
isolated and manipulated genetic Sequence is an "isolated 
polypeptide', as used herein, even if expressed in a homolo 
gous cell type. Synthetically made forms or molecules 
expressed by heterologous cells are inherently isolated mol 
ecules. 
"Recombinant nucleic acid' is a nucleic acid which is not 
naturally occurring, or which is made by the artificial 
combination of two otherwise Separated Segments of 
Sequence. This artificial combination is often accomplished 
by either chemical Synthesis means, or by the artificial 
manipulation of isolated Segments of nucleic acids, e.g., by 
genetic engineering techniques. Such is usually done to 
replace a codon with a redundant codon encoding the same 
or a conservative amino acid, while typically introducing or 
removing a Sequence recognition site. Alternatively, it is 
performed to join together nucleic acid Segments of desired 
functions to generate a desired combination of functions. 
“Substantial homology or similarity”. A nucleic acid or 
fragment thereof is “substantially homologous” (“or Sub 
Stantially similar') to another if, when optimally aligned 
(with appropriate nucleotide insertions or deletions) with the 
other nucleic acid (or its complementary Strand), there is 
nucleotide sequence identity in at least about 60% of the 
nucleotide bases, usually at least about 70%, more usually at 
least about 80%, preferably at least about 90%, and more 
preferably at least about 95-98% of the nucleotide bases. 
To determine homology between two different nucleic 
acids, the percent homology is to be determined using the 
BLASTN program “BLAST 2 sequences”. This program is 
available for public use from the National Center for Bio 
technology Information (NCBI) over the Internet (http:// 
www.ncbi.nlm.nih.gov/gorf/bl2.html) (Altschul et al., 
1997). The parameters to be used are whatever combination 
of the following yields the highest calculated percent homol 
ogy (as calculated below) with the default parameters shown 
in parentheses: 
Program-blastin 
Matrix-O BLOSUM62 
Reward for a match-0 or 1 (1) 
Penalty for a mismatch-0, -1, -2 or -3 (-2) 
Open gap penalty—0, 1, 2, 3, 4 or 5 (5) 
Extension gap penalty-0 or 1 (1) 
Gap x dropoff 0 or 50 (50) 
Expect-10 
Along with a variety of other results, this program shows 
a percent identity across the complete Strands or acroSS 
regions of the two nucleic acids being matched. The pro 
gram ShowS as part of the results an alignment and identity 
of the two Strands being compared. If the Strands are of equal 
length then the identity will be calculated acroSS the com 
plete length of the nucleic acids. If the Strands are of unequal 
lengths, then the length of the shorter nucleic acid is to be 
used. If the nucleic acids are quite Similar acroSS a portion 
of their sequences but different across the rest of their 
sequences, the blastin program “BLAST 2 Sequences” will 
show an identity acroSS only the Similar portions, and these 
portions are reported individually. For purposes of deter 
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mining homology herein, the percent homology refers to the 
Shorter of the two Sequences being compared. If any one 
region is shown in different alignments with differing per 
cent identities, the alignments which yield the greatest 
homology are to be used. 
Alternatively, Substantial homology or (similarity) exists 
when a nucleic acid or fragment thereof will hybridize to 
another nucleic acid (or a complementary Strand thereof) 
under Selective hybridization conditions, to a Strand, or to its 
complement. Selectivity of hybridization exists when 
hybridization which is substantially more selective than total 
lack of Specificity occurs. Typically, Selective hybridization 
will occur when there is at least about 55% homology over 
a stretch of at least about 14 nucleotides, preferably at least 
about 65%, more preferably at least about 75%, and most 
preferably at least about 90%. See, Kanehisa, 1984. The 
length of homology comparison, as described, may be over 
longer Stretches, and in certain embodiments will often be 
over a stretch of at least about nine nucleotides, usually at 
least about 20 nucleotides, more usually at least about 24 
nucleotides, typically at least about 28 nucleotides, more 
typically at least about 32 nucleotides, and preferably at least 
about 36 or more nucleotides. 
Nucleic acid hybridization will be affected by Such con 
ditions as Salt concentration, temperature, or organic 
Solvents, in addition to the base composition, length of the 
complementary Strands, and the number of nucleotide base 
mismatches between the hybridizing nucleic acids, as will 
be readily appreciated by those skilled in the art. Stringent 
temperature conditions will generally include temperatures 
in excess of 30° C., typically in excess of 37 C., and 
preferably in excess of 45 C. Stringent salt conditions will 
ordinarily be less than 1000 mM, typically less than 500 
mM, and preferably less than 200 mM. However, the com 
bination of parameters is much more important than the 
measure of any Single parameter. The Stringency conditions 
are dependent on the length of the nucleic acid and the base 
composition of the nucleic acid and can be determined by 
techniques well known in the art. See, e.g., Wetmur and 
Davidson, 1968. 
Probe Sequences may also hybridize Specifically to duplex 
DNA under certain conditions to form triplex or other higher 
order DNA complexes. The preparation of such probes and 
suitable hybridization conditions are well known in the art. 
The terms “substantial homology” or “substantial 
identity”, when referring to polypeptides, indicate that the 
polypeptide or protein in question exhibits at least about 
30% identity with an entire naturally-occurring protein or a 
portion thereof, usually at least about 70% identity, more 
usually at least about 80% identity, preferably at least about 
90% identity, and more preferably at least about 95% 
identity. 
Homology, for polypeptides, is typically measured using 
Sequence analysis Software. See, e.g., the Sequence Analysis 
Software Package of the Genetics Computer Group, Uni 
versity of Wisconsin Biotechnology Center, 910 University 
Avenue, Madison, Wis. 53705. Protein analysis software 
matches Similar Sequences using measures of homology 
assigned to various Substitutions, deletions and other modi 
fications. Conservative Substitutions typically include Sub 
Stitutions within the following groups: glycine, alanine; 
Valine, isoleucine, leucine; aspartic acid, glutamic acid; 
asparagine, glutamine, Serine, threonine; lysine, arginine; 
and phenylalanine, tyrosine. 
“Substantially similar function” refers to the function of a 
modified nucleic acid or a modified protein, with reference 
to the wild-type malA or lacS nucleic acid or wild-type malA 
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or lacS polypeptide. The modified polypeptide will be 
Substantially homologous to the wild-type polypeptide and 
will have substantially the same function. The modified 
polypeptide may have an altered amino acid Sequence and/or 
may contain modified amino acids. In addition to the Simi 
larity of function, the modified polypeptide may have other 
useful properties, Such as a longer half-life. The Similarity of 
function (activity) of the modified polypeptide may be 
Substantially the same as the activity of the wild-type 
polypeptide. Alternatively, the Similarity of function 
(activity) of the modified polypeptide may be higher than the 
activity of the wild-type polypeptide. The modified polypep 
tide is Synthesized using conventional techniques, or is 
encoded by a modified nucleic acid and produced using 
conventional techniques. The modified nucleic acid is pre 
pared by conventional techniques. A nucleic acid with a 
function Substantially similar to the wild-type gene function 
produces the modified protein described above. 
As used herein, “thermostable” when referring to an 
enzyme means an enzyme which can function at high 
temperatures and is stable to heat, heat resistant, and will not 
denature at high temperatures. 
A polypeptide “fragment”, “portion' or “segment' is a 
Stretch of amino acid residues of at least about five to Seven 
contiguous amino acids, often at least about Seven to nine 
contiguous amino acids, typically at least about nine to 13 
contiguous amino acids and, most preferably, at least about 
20 to 30 or more contiguous amino acids. 
The polypeptides of the present invention, if Soluble, may 
be coupled to a Solid-phase Support, e.g., nitrocellulose, 
nylon, column packing materials (e.g., Sepharose beads), 
magnetic beads, glass Wool, plastic, metal, polymer gels, 
cells, or other Substrates. Such Supports may take the form, 
for example, of beads, Wells, dipsticks, or membranes. 
The practice of the present invention employs, unless 
otherwise indicated, conventional techniques of chemistry, 
molecular biology, microbiology, recombinant DNA, 
genetics, and immunology. See, e.g., Maniatis et al., 1982; 
Sambrook et al., 1989; Ausubel et al., 1992; Glover, 1985; 
Anand, 1992; Guthrie and Fink, 1991. 
Preparation of Recombinant or Chemically Synthesized 
Nucleic Acids: Vectors, Transformation, Host Cells 
Large amounts of the polynucleotides of the present 
invention may be produced by replication in a Suitable host 
cell. Natural or Synthetic polynucleotide fragments coding 
for a desired fragment will be incorporated into recombinant 
polynucleotide constructs, usually DNA constructs, capable 
of introduction into and replication in a prokaryotic or 
eukaryotic cell. Usually the polynucleotide constructs will 
be Suitable for replication in a unicellular host, Such as yeast 
or bacteria, but may also be intended for introduction to 
(with and without integration within the genome) cultured 
plant, mammalian or other eukaryotic cell lines. The puri 
fication of nucleic acids produced by the methods of the 
present invention are described, e.g., in Sambrook et al., 
1989 or Ausubel et al., 1992. 
The polynucleotides of the present invention may also be 
produced by chemical Synthesis, e.g., by the phosphoramid 
ite method described by Beaucage and Caruthers, 1981, or 
the triester method according to Matteucci and Caruthers, 
1981, and may be performed on commercial, automated 
oligonucleotide Synthesizers. A double-Stranded fragment 
may be obtained from the Single-Stranded product of chemi 
cal Synthesis either by Synthesizing the complementary 
Strand and annealing the Strand together under appropriate 
conditions or by adding the complementary Strand using 
DNA polymerase with an appropriate primer Sequence. 
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Polynucleotide constructs prepared for introduction into a 
prokaryotic or eukaryotic host may comprise a replication 
System recognized by the host, including the intended poly 
nucleotide fragment encoding the desired polypeptide, and 
will preferably also include transcription and translational 
initiation regulatory Sequences operably linked to the 
polypeptide encoding Segment. Expression vectors may 
include, for example, an origin of replication or autono 
mously replicating sequence (ARS) and expression control 
Sequences, a promoter, an enhancer and necessary proceSS 
ing information sites, Such as ribosome-binding Sites, RNA 
Splice Sites, polyadenylation sites, transcription terminator 
Sequences, and mRNA Stabilizing Sequences. Such vectors 
may be prepared by means of Standard recombinant tech 
niques well known in the art and discussed, for example, in 
Sambrook et al., 1989 or Ausubel et al., 1992. 
An appropriate promoter and other necessary vector 
Sequences will be Selected So as to be functional in the host, 
and may include, when appropriate, those naturally associ 
ated with the malA gene. Examples of workable combina 
tions of cell lines and expression vectors are described in 
Sambrook et al., 1989 or Ausubel et al., 1992; see also, e.g., 
Metzger et al., 1988. Many useful vectors are known in the 
art and may be obtained from Such vendors as Stratagene, 
New England Biolabs, Promega Biotech, and others. Pro 
moterS Such as the trip, lac and phage promoters, tRNA 
promoters and glycolytic enzyme promoters may be used in 
prokaryotic hosts. Useful yeast promoters include promoter 
regions for metallothionein, 3-phosphoglycerate kinase or 
other glycolytic enzymes Such as enolase or glyceraldehyde 
3-phosphate dehydrogenase, enzymes responsible for mal 
tose and galactose utilization, and others. Vectors and pro 
moters Suitable for use in yeast expression are further 
described in Hitzeman et al., EP 73,675A. Appropriate 
non-native mammalian promoters might include the early 
and late promoters from SV40 (Fiers et al., 1978) or pro 
moters derived from murine Molony leukemia virus, mouse 
tumor virus, avian Sarcoma viruses, adenovirus II, bovine 
papilloma virus or polyoma. Insect promoters may be 
derived from baculovirus. In addition, the construct may be joined to an amplifiable gene (e.g., DHFR) So that multiple 
copies of the gene may be made. For appropriate enhancer 
and other expression control Sequences, See also Enhancers 
and Eukaryotic Gene Expression, Cold Spring Harbor Press, 
Cold Spring Harbor, N.Y. (1983). See also, e.g., U.S. Pat. 
Nos. 5,691,198; 5,735,500; 5,747,469 and 5,436,146. 
While Such expression vectors may replicate 
autonomously, they may also replicate by being inserted into 
the genome of the host cell, by methods well known in the 
art. 
Expression and cloning vectors will likely contain a 
Selectable marker, a gene encoding a protein necessary for 
survival or growth of a host cell transformed with the vector. 
The presence of this gene ensures growth of only those host 
cells which express the inserts. Typical Selection genes 
encode proteins that a) confer resistance to antibiotics or 
other toxic Substances, e.g. amplicillin, neomycin, 
methotrexate, etc., b) complement auxotrophic deficiencies, 
or c) Supply critical nutrients not available from complex 
media, e.g., the gene encoding D-alanine racemase for 
Bacilli. The choice of the proper selectable marker will 
depend on the host cell, and appropriate markers for differ 
ent hosts are well known in the art. 
The vectors containing the nucleic acids of interest can be 
transcribed in vitro, and the resulting RNA introduced into 
the host cell by well-known methods, e.g., by injection (see 
Kubo, et al., 1988), or the vectors can be introduced directly 
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into host cells by methods well known in the art, which vary 
depending on the type of cellular host, including electropo 
ration; transfection employing calcium chloride, rubidium 
chloride calcium phosphate, DEAE-dextran, or other Sub 
stances, microprojectile bombardment, lipofection; infec 
tion (where the vector is an infectious agent, Such as a 
retroviral genome); and other methods. See generally, Sam 
brook et al., 1989 and Ausubel et al., 1992. The introduction 
of the polynucleotides into the host cell by any method 
known in the art, including, interalia, those described above, 
will be referred to herein as “transformation.” The cells into 
which have been introduced nucleic acids described above 
are meant to also include the progeny of Such cells. 
Large quantities of the nucleic acids and polypeptides of 
the present invention may be prepared by expressing the 
malA nucleic acid or portions thereof in Vectors or other 
expression vehicles in compatible prokaryotic or eukaryotic 
host cells. The most commonly used prokaryotic hosts are 
Strains of Escherichia coli, although other prokaryotes, Such 
as Bacillus Subtilis or Pseudomonas may also be used. 
Mammalian or other eukaryotic host cells, Such as those 
of yeast, filamentous fungi, plant, insect, or amphibian or 
avian Species, may also be useful for production of the 
proteins of the present invention. Propagation of mammalian 
cells in culture is perse well known. See, Jakoby and Pastan 
(eds.), 1979. Examples of commonly used mammalian host 
cell lines are VERO and HeLa cells, Chinese hamster ovary 
(CHO) cells, and WI38, BHK, and COS cell lines, although 
it will be appreciated by the skilled practitioner that other 
cell lines may be appropriate, e.g., to provide higher 
expression, desirable glycosylation pattems, or other fea 
tures. An example of a commonly used insect cell line is 
SF9. 
Clones are Selected by using markers depending on the 
mode of the vector construction. The marker may be on the 
same or a different DNA molecule, preferably the same 
DNA molecule. Production of a particular product based on 
temperature Sensitivity may serve as an appropriate marker. 
In prokaryotic hosts, the transformant may be Selected, e.g., 
by resistance to amplicillin, tetracycline or other antibiotics. 
Prokaryotic or eukaryotic cells transformed with the poly 
nucleotides of the present invention will be useful not only 
for the production of the nucleic acids and polypeptides of 
the present invention, but also, for example, in Studying the 
characteristics of malA polypeptide. 
The probes and primers based on the malA gene Sequence 
disclosed herein are used to identify homologous malA gene 
Sequences and proteins in other species. These gene 
Sequences and proteins are used in the methods described 
herein. 
Method of Use: Bioprocessing of Plant Carbohydrates 
Bioprocessing of plant carbohydrates Such as Starch cur 
rently necessitates commodity enzyme additives to acceler 
ate polysaccharide hydrolysis. Depolymerization is accom 
plished by heat-based hydration followed by the addition of 
microbial-derived thermostable hydrolases. To simplify the 
current process, transgenic tobacco plants of the invention 
were created which expressed hyperthermophilic glycosyl 
hydrolase derived from the archaeon Sulfolobus Solfatari 
cus. Hydrolysis, by recombinant glycosyl hydrolase, of 
endogenous Starch present in Starch-containing plant tissues 
Such as corn, wheat, milo and the like, was accomplished by 
processing milled tissue, at high temperatures to activate the 
recombinant protein. Alternatively, plant Starch was first 
Separated from other components of the plant tissue and then 
hydrolyzed by addition of recombinantly produced glycosyl 
hydrolase and Subjecting the mixture to high temperatures. 
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Conventionally, in the wet milling process there is Separa 
tion of the germ, hull gluten. In order to Separate Starch from 
the corn kernel, for example, the kernels are Steeped in an 
aqueous Solution under controlled conditions to Soften the 
kernels and facilitate Separation of the kernels components. 
After Steeping, the aqueous Solution is ground and Screened 
So as to Separate the fibrous material and endosperm par 
ticles from the Soluble protein, Starch and gluten. The Starch 
and gluten are then Separated by their differences in density, 
for example, by high-rate Washing centrifugation. 
Alternatively, other methods may be employed in the iso 
lation of Starch from Starch-containing plant tissue Such as 
addition of cellulose at the milling Step or Separation of 
Starch from oil-bearing Solids by centrifugation to promote 
an oil-Solid phase Separation. 
Enzyme Substrates included exogenous polysaccharides 
of defined composition and plant extracts enriched for 
endogenous polysaccharides. Direct conversion of plant 
tissue into free Sugar was demonstrated by the production of 
high cell density microbial cultures resulting from using 
heated plant extracts as growth media. 
EXAMPLES 
The following examples are provided to further illustrate 
the present invention and are not intended to limit the 
invention beyond the limitations Set forth in the appended 
claims. 
Example 1 
Cloning and Characterization of the Sulfolobus 
Solfataricus malA Gene 
Archaea constitute a third domain of organisms along 
with eubacteria and eukaryotes. The Archaea was first 
recognized in the early 1970s and includes Single-celled 
organisms that are found in extreme environments Such as 
Volcanic hot Springs and hypothermal vents in the deep 
ocean. Members of the domain include the Methanogen, 
Halophile and Sulfolobus genera. Members of the genus 
Sulfolobus have been assigned to the crenarchaeotal Subdi 
vision of the domain Archaea, of which Sulfolobus com 
prises the largest genus. (Burggraf, et al., 1997). S. Solfa 
taricus is an aerobic, extremely thermophilic organism 
found in acidic hot Springs. The ability of thermophiles, 
including members of the Sulfolobus genus to grow on a 
variety of Sugars and polysaccharides, is a result of their 
Synthesis of alpha-glucosidases and beta-glycosidases. To 
investigate poly-Saccharide utilization of maltose by Sul 
folobus Species, the gene encoding the alpha-glucosidase 
from S. Solfataricus was cloned and characterized. 
Cloning of the gene was accomplished by using gene 
specific PCR primers derived from the S. Solfataricus alpha 
glucosidase protein Sequence Rolfsmeir et al., 1998. Amino 
acid Sequencing indicated the mature N-terminal alpha 
glucosidase sequence was MQTIKIYENLGVYLWIGEP 
(SEQ.ID.NO:3). Since the purified S. Solfataricus alpha 
glucosidase is generally resistant to proteolytic degradation 
(Rolfsmeir and Blum, 1995) protein fragments for internal 
N-terminal Sequence analysis were generated by chemical 
cleavage with cyanogen bromide. A fragment of 19 kDa was 
selected and yielded the N-terminal sequence VGKYL 
LYAPI (SEQ.ID.NO:4). The resulting amino acid sequence 
information was used to design degenerate oligonucleotides 
which were then used to amplify a DNA fragment of 1.6 kb 
by PCR. A 731-bp HindIII-EcoRV fragment derived from 
the resulting 1.6-kb PCR product was used to generate a 
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radio labeled probe for Southern hybridization to verify the 
origin of the amplification product. This probe croSS 
hybridized with single DNA fragments of 1.2, 1.7, and 1.4 
kb in HindIII, Xbal, and HincII genomic digests, 
respectively, of S. Solfataricus DNA. The probe was used to 
Screen a genomic S. SolfataricuS phage 2. library consisting 
of 672 individually propagated recombinant phages by 
Southern blot analysis. A Single isolate was identified 
(0.7F7), which contained a 15.1-kb insert of S. Solfataricus 
DNA. Southern blot analysis of restriction digests of the 
2.7F7 phage was performed with the PCR-derived probe. 
Cross-hybridizing restriction fragments which were identi 
cal in size to those observed previously with genomic DNA 
were observed and indicated that the coding region for 
alpha-glucosidase is contained in a 4.3-kb BamHI fragment 
of the 27F7 insert. This 4.3-kb BamHI fragment was sub 
cloned and Sequenced. The Sequence located immediately 5' 
to the malA coding region was Subcloned from 27F7 as a 
2.3-kb SacI-HindIII fragment. A 344-bp SacI-BamHI frag 
ment from the extreme 5' end of this fragment was used as 
a Southern blot probe to identify the next upstream over 
lapping 2 clone from the genomic S. SolfataricuS 98/2 
library. This isolate was named 2-1H4. A 4.1-kb HindIII 
SacI fragment which cross-hybridized to the same SacI 
BamHI344-bp fragment was subcloned from 2-1H4. A 2-kb 
segment of this 4.1-kb HindIII-SacI fragment was 
Sequenced to complete the analysis of putative genes lying 
5' to malA. Analysis of regions lying 3' to the malA coding 
region was done with a 1.8-kb 3' overlapping HindIII 
HindIII fragment derived from 27F7. The resulting sequence 
comprising a nearly 7-kb DNA contig. has been deposited in 
Gen Bank (accession number AF042494, incorporated 
herein by reference). 
The alpha-glucosidase open reading frame (ORF) (malA) 
of the present invention was identified by comparison of 
peptide Sequences derived from the N-terminal and internal 
N-terminal Sequencing of the natural protein to the deduced 
amino acid sequence (SEQ ID NO:2). The malA sequence 
comprises 2,083 bp encoding a protein of 693 amino acids 
with a predicted mass of 80.5 kDa. This closely corresponds 
to the apparent mass of the previously purified natural 
enzyme subunit (Rolfsmeier, et al., 1995). Sequence analy 
sis of the deduced malA product identified a glycosyl 
hydrolase motif at residues 316 to 323 and an ATP/GTP 
binding site motif (P loop) at residues 583 to 590 (SEQ ID 
NO: 2). The glycosyl hydrolase motif contains the putative 
active-site asparagine previously identified for the human 
alpha-glucosidase gene (Hermans, et al., 1991). Only two 
cysteine residues are evident, consistent with the low cyS 
teine content Seen previously in thermophilic proteins. There 
are 14 methionine residues, and the predicted mass of the 
largest Sequence uninterrupted by methionines is 19 kDa as 
Suggested by the-cyanogen bromide cleavage pattern of the 
alpha-glucosidase. Examination of the 7.05 kb contig iden 
tified several ORFs (FIG. 1A) with G+C contents of 37 to 38 
mol %, as expected from previous analysis (DeRosa, et al., 
1975; Felsenstein, 1989). No sequence homologs of these 
ORFS were evident in Searches of Sequence databases. 
Within this contig, malA is flanked on the 5' side by an 
unusual 1-kb intergenic region. It exhibits a G+C content of 
30.8 mol %, a value considerably lower than that for the 
flanking coding regions. 
Northern blot analysis of the malA region identified 
transcripts for malA and an upstream ORF located 5' to the 
1-kb intergenic region. The malA transcription start Site was 
located by primer extension analysis (Trienzenberg, 1992) to 
a guanine residue 8 bp 5' of the malA Start codon. Gel 
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mobility shift analysis (Buratowski et al., In Ausubei, et al., 
1996) of the malA promoter region Suggests that sequences 
3' to position about 70 (SEQ ID NO: 1) including a consen 
SuS archaeal TATA box, play an essential role in malA. 
There is a potential archaeal promoter Sequence located 
32 bp 5' to the start codon of the malA gene (FIG. 1B). The 
putative promoter (TTTATA) closely matches the consensus 
promoter sequence for Sulfolobus (Reiter, et al., 1988). A 
box B motif (TGA) (Reiter, et al., 1988) is also evident 7 bp 
5' to the malA start codon. Primer extension analysis indi 
cated that malA transcription initiates on the guanine of the 
putative box B motif. The mapped start site is 8bp 5' to the 
malA Start codon. Although there is a potential ribosome 
binding site spanning positions -3 to +3 (FIG. 2), which are 
complementary to the six 3'-terminal bases of the 16S rRNA 
of S. Solfataricus (Kurosawa and Itoh, 1993; Zillig, 1993), 
this sequence overlaps in part the Site of malA transcription 
initiation. The utilization of this sequence for the initiation 
of translation is therefore unclear. The malA mRNA is only 
Slightly larger than the coding region of the gene. Since 
transcription initiates very close to the Start of the coding 
region, termination of transcription of the-gene must occur 
close to the end of malA. The near-consensus terminator 
sequence (TTTTTCA) (Daalgard, 1983) located immedi 
ately 3' to the Stop codon of malA may play a role in this 
process (FIG. 2). 
The interaction between purified archaeal TATA binding 
proteins and archaeal promoters have been characterized by 
gel shift analysis (Qureshi, 1995). Crude cell extracts pre 
pared as described previously for use in an in vitro tran 
scription system (Hudepohl, et al., 1990) were used as 
Sources of DNA binding proteins. The probe was a 233-bp 
EcoRI fragment which starts 151 bp 5' to the malA tran 
Scription start Site and extends 80 bp into the malA tran 
Script. Addition of crude cell extract resulted in the forma 
tion of two retarded protein DNA complexes. Both 
complexes were eliminated by addition of the 233-bp EcoRI 
malA promoter fragment as an unlabeled competitor DNA. 
The more rapidly migrating complex (FIG. 4, complex B) 
was lost in response to addition of competitor-DNA con 
sisting of a 231-bp EcoRI-PvuII fragment from plasmid 
pUC19, indicating that it was the result of nonspecific 
interactions. Addition of a competitor DNA comprised of a 
deletion derivative of the malA EcoRI promoter fragment, 
lacking Sequences from bp -33 to +81, including the TATA 
box (FIG. 1B, malA p-S), again eliminated only the lower 
band. These results Suggest that Sequences located between 
bp -33 and +81 (FIG. 2) are important features of the malA 
promoter. 
Amino acid Sequences of alpha-glucosidases and the 
related Sucrase isomaltases were retrieved from the Swiss 
Prot and EMBL/Gen-Bank/DDBJ databases. A multiple 
Sequence alignment of 6 bacterial and 11 eukaryotic 
Sequences in addition to the S. Solfataricus Sequence was 
made. The region of the S. SolfataricuS alpha-glucosidase 
used for the alignment included 569 amino acid residues 
spanning positions 50 to 618. The S. Solfataricus alpha 
glucosidase is the only representative of the archaea, Since 
no other archaeal alpha-glucosidases were found in the 
databases. A conserved Stretch of amino acids located in the 
middle of the three fungal Sequences was deleted to mini 
mize Sequence gaps in the alignment. The alignment of 
Sequences then was analyzed by distance, parSimony, and 
maximum-likelihood methods. The E. coli malZ gene prod 
uct was used as the outgroup. The Sequences clustered into 
two groups typical of either eubacterial or eukaryotic 
affiliation, under all three methods of analysis. Nearest 
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neighbor distance analysis and parSimony analysis indicated 
that the S. Solfataricus alpha-glucosidase is most closely 
related to mammalian enzyme homologs. Maximum 
likelihood analysis gave similar results. 
Example 2 
Distribution of the malA Gene Among Sulfolobus 
Species 
Southern blot analysis with a malA gene probe was 
performed to analyze the distribution of this gene among the 
three commonly cultivated Sulfolobus species. Two isolates 
of S. Solfataricus were included in the analysis, strain 98/2 
from Yellowstone National Park and strain P2 (DSM 1617) 
from Italy. Genomic digests prepared with EcoRV (FIG.3A) 
or HindIII (FIG. 3B) were then probed under stringent 
hybridization conditions with a 731-bp EcoRV-HindIII 
malA gene fragment encompassing nucleotides 714 to 1445 
of the malA coding region (FIG. 2). Both strains of S. 
Solfataricus exhibited strongly hybridizing bands of 2.9 kb 
following EcoRV digestion and 1.2 kb following HindIII 
digestion(FIG. 3, lanes 3 and 4), in agreement with the 
Southern blot results obtained previously with the 731-bp 
HindIII-EcoRV probe fragment derived from the initial 
malA PCR product. For S. Shibatae, single weakly hybrid 
izing bands of 0.65 kb following EcoRV digestion (FIG.3A, 
lane 1) and 3.7 kb following HindIII digestion (FIG. 3B, 
lane 1) were also observed. No cross-hybridization was 
observed, however, between the S. Solfataricus malA gene 
and S. acidocaldarius genomic DNA digests (FIGS. 3A and 
B, lanes 2). Lack of a malA homolog or significant 
C-glucosidase activity in S. acidocaldarius may be due to 
the inability of S. acidocaldarius to utilize maltose as a Sole 
carbon and energy source. (Rolfsmeier, et al. 1998). An 
alpha-glucosidase thus may be essential for utilization of 
maltose among certain members of the genus Sulfolobus. 
This represents a distinguishing physiological feature for 
Sulfolobus species identification. 
Example 3 
Isolation of DNA Encoding for Thermostable 
Alpha-glucosidase from SulfolobuS SolfataricuS 
Isolation of DNA encoding thermostable C-glucosidases 
from hyperthermophilic members of Sulfolobus genus can 
be accomplished using primers based on the glycosyl hydro 
lase motif at residues 316 to 323 and the ATP/GTP binding 
site motif (P loop) at residues 583 to 590 (single underline) 
as shown in FIG. 2. The amino acid Sequence information 
can be used to design degenerate oligonucleotides which can 
be used to amplify DNA fragments by PCR. Restriction 
fragments derived from the PCR products can be used to 
generate a radio labeled probe for Screening genomic or 
cDNA libraries of Sulfolobus species. Isolates can be iden 
tified and restriction fragments can be analyzed for croSS 
hybridization and Sub-cloning. Isolation of malA homologs 
from other closely related archaea can be accomplished by 
Screening recombinant DNA libraries of the target organism 
with probes derived from the malA gene. To obtain 
homologs from more distantly related archaea antibodies 
can be raised against malA as probes to Screen expression 
libraries. 
Example 4 
Expression of Recombinant Alpha-glucosidase 
Activity in Escherichia coli and its Purification and 
Characterization 
malA gene encoding of hyperthermophilic alpha 
glucosidase, was confirmed by expression in E. coli. The 
recombinant enzyme was then purified and characterized. 
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A 2.1-kb region spanning bp 141 to 2265 (FIG. 2), 
encompassing the malA coding region and 30 bp of flanking 
Sequence, was blunted and cloned into the SmaI site of 
pUC19. This construct was then digested with Kpn1 and 
Pst1, and the resulting 2.1-kb fragment was Subcloned into 
the Kpn1 and Pst1 sites of plasmid pLITMUS 29 (New 
England Biolabs). The pITIMUS 29 derivative was then 
digested with Stu1 and PvulI and religated to itself to 
remove a T7 promoter located 3' to the malA sequence. The 
resulting plasmid was introduced into E. coli DH5C. for 
production of the recombinant protein by using Stationary 
phase cell Suspensions, typically in 0.5 liter amounts. 
Purification of the recombinant enzyme to apparent 
homogeneity employed heat fractionation of clarified cell 
Sonicates followed by anion-exchange fast protein liquid 
chromatography and gel filtration fast protein liquid chro 
matography as described by Rolfsmeier, et al., 1995. The 
recombinant S. Solfataricus alpha-glucosidase exhibited Sig 
nificant recalcitrance to denaturation as indicated by its 
behavior during denaturing SDS-PAGE. Despite boiling in 
the presence of 2% (wt/vol) SDS for 10 minutes, the 
alpha-glucosidase failed to enter the Separating gel and 
instead migrated in Significant amounts (representing 45% 
of the total observed protein) in the Stacking gel. However, 
95% of the natural enzyme treated in an identical manner 
was in the multimeric form (Rolfsmeier, et al., 1995), 
Suggesting that the recombinant enzyme dissociates more 
readily under these conditions. Complete denaturation of the 
recombinant alpha-glucosidase required additional treat 
ment with 6 M guanidine hydrochloride, resulting in exclu 
sive formation of the 80-kDa monomer. Assays for alpha 
glucosidase activity with p-nitrophenyl-C-D- 
glucopyranoside were performed as described by 
Rolfsmeier, et al., 1995. In enzymatic assays for hydrolysis 
of maltose and glycogen, release of glucose was monitored 
with a glucose oxidase assay kit (Sigma) as described by 
Rolfsmeier, et al., 1995. 
Increasing expression is accomplished by changing 
codons which are not heavily used in the host species, 
whether microbial or plant. Codon usage tables are available 
for many plant hosts, including tobacco, thus the identifi 
cation of which codons to change and what to change them 
to as well as the method to do it are well known in the art. 
The purified, recombinant enzyme hydrolyzes p-nitro 
phenyl-O-D-glucopyranoside with a Km of 2.16 mM and a 
V of 3.08 umol of p-nitrophenol/min at 85 C. It exhib 
ited a pH optimum for maltose hydrolysis of 4.5 (FIG. 4A). 
In contrast to its apparent greater tendency to dissociate 
during SDS-PAGE, the recombinant alpha-glucosidase 
exhibits greater thermoStability than the natural enzyme with 
a half-life of 39 hat 85°C. at a pH of 6.0. The half-life for 
the natural enzyme is 11 h at 85°C. (Rolfsmeier et al., 1995). 
Alpha-glucosidases of mammalian origin are generally 
distinguished from those of higher plants and eubacteria by 
their affinities for glycogen as a Substrate. Surprisingly, 
glycogen is hydrolyzed efficiently by alpha-glucosidase 
from S. Solfataricus. The recombinant alpha-glucosidase 
exhibits a pH optimum for glycogen hydrolysis of 5.5 (FIG. 
4B), a Km of 64.9 mg/ml, and a V of 1.0 umol of 
glucose/min at 85 C. 
Recombinant enzyme purification of beta-glycosidase 
was performed using transformants of E. coli DH5C. (Gibco 
BRL) harboring the lacS expression plasmid pBN55. The 
Strain was grown at 37 C. with vigorous shaking in 4 liters 
of LB medium containing amplicillin (100 tug/ml) until the 
cells reached Stationary phase. Cells were harvested by 
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centrifugation, resuspended in 30 mM morpholinepropane 
sulfonic acid, pH 8.0 (MOPS buffer) and lysed by Sonication 
at 4 C. The resulting lysates were clarified by centrifugation 
(3,000xg for 30 min.) and then heated at 85°C. for 30 min. 
and reclarified by centrifugation. The heating and centrifu 
gation procedure was then repeated a Second time. The 
heat-treated Supernatants were concentrated by ultrafiltra 
tion using a YM3 (Amicon) membrane. 
The concentrated Supernatants were applied to a Mono Q 
FPLC (fast protein liquid chromatography) column 
(Parmacia) previously equilibrated with MOPS buffer. The 
recombinant B-glycosidase was eluted with linear gradients 
of Sodium chloride in MOPS buffer. Active fractions of the 
enzyme were identified by enzyme assay, pooled, concen 
trated by ultrafiltration using a PM10 (Amicon) membrane, 
and dialyzed into 100 mM sodium phosphate buffer (pH 
6.0). The dialyzed samples were applied to a Superdex 200 
HR 10/30 FPLC column (Pharmacia) previously equili 
brated with 100 mM sodium phosphate (pH 6.0). Active 
fractions were again pooled and concentrated by ultrafiltra 
tion. 
Example 5 
Transformation of Tobacco Plants by 
Agrobacterium tumefaciens Transformed with a 
Binary Plasmid Containing the malA or lacS Genes 
During the cloning of the malA gene into the plant vector, 
candidate colonies were Screened by growing overnight in 
LB broth containing the appropriate antibiotic, pelleting the 
cells and resuspending them in 0.1 M Sodium acetate at pH 
4.5. ASSay for alpha-glucosidase was performed with para 
nitrophenyl-C-D-glucopyranoside as described in 
Rolfsmeier, et al., 1995. In order to construct the binary 
plasmid, the malA gene which had been cloned from a 
genomic library of Sulfolobus Solfataricus strain 98/2 
(pBN56; Rolfsmeier et al., 1998), containing the coding 
Sequence and about 30 bp of 5" flanking Sequence, was first 
cloned into the vector pGEM 7Zf+ (Promega) to pick up 
useful restriction sites. The malA open reading frame and 30 
bp lying both 5' and 3' was then cloned between the 
enhanced 35S promoter (5) and the 35S polyadenylation site 
(3) of the pRTL2 plasmid which was provided by J. C. 
Carrington, after the TEV leader Sequence (Carrington and 
Freed, 1990; Carrington, et al., 1990) had been removed by 
digestion with XhoI and Bam HI. The resulting expression 
cassette was Subcloned into the multiple cloning site of the 
binary vector pPZP112 (Hajdukiewicz, et al., 1994)at the Pst 
I site (near right T-DNA border) to produce the construct 
pPB709, shown in FIG.1. The pPZP112 vector contains the 
neomycin phosphotransferase (NPT II) gene under the 35S 
promoter within the T-DNA near the left border, resulting in 
a plasmid in which the gene of interest inserts first into the 
genome (Hajdukiewicz, et al., 1994). The lacS gene includ 
ing its bacterial expression System and antibodies were as 
described in Haseltine, et al., 1999(a). A pPZP112 derivative 
expressing lacS was constructed using the same Strategy as 
described for malA. 
The resulting binary vector plasmid constructs were used 
to transform Agrobacterium tumefaciens strain C58C1 by 
the freeze-thaw method (An et al., 1988). The bacteria was 
then used to transform tobacco (Nicotiana tabacum cv. 
Xanthi) by the leaf disk method (Horsch et al., 1985). 
Rooted regenerants were identified as transformants by 
detection of NPT II in leaf tissue with the ELISA kit (5 
Prime 3 Prime, Inc.), according to the manufacturer's 
instructions. 
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After transformation and regeneration of tobacco leaf 
disks with Vector containing the malA or lacS gene, 17 
rooted tobacco regenerants were identified by their positive 
reaction on NPT II ELISA as having been transformed with 
the T-DNA from Agrobacterium tumefaciens containing the 
gene. 
Based on the methods described herein and the data 
presented, those of skill in the art would be able to construct 
plants expressing both glycosyl hydrolases. 
Example 6 
Preparation of Enzyme Concentrate from Tobacco 
Extract 
To obtain tobacco leaf extract for assays, approximately 
100 g of tobacco (five 1.1 cm diameter disk punches) leaves 
were harvested, rinsed with distilled water, midribs removed 
and weighed. Leaves were then ground to a powder in liquid 
nitrogen and ground again with a sterilized pestle. The 
extracts were then clarified by centrifugation at 14,000 rpm 
for 10 minutes at room temperature. The resulting Superna 
tant was heat treated for 1 hour at 85 C. and clarified by 
Spinning at 14,000 rpm for 10 minutes at room temperature. 
The Supernatant was collected and assayed for alpha 
glucosidase or beta-glycosidase enzyme activity by measur 
ing the hydrolysis of p-nitrophenyl-alpha-glucopyranoside 
(alpha-PNPG) and p-nitrophenyl-beta-D-glucopyranoside 
(beta-PNPG), respectively, as previously described 
(Rolfsmeier, et al., 1998; Haseltine, et al., 1999(a)). Plant 
tissue extracts for Studies on hydrolysis of added defined 
Substrates were prepared using 100 g of tobacco leaves were 
harvested and grinded to a fine powder in liquid nitrogen. 
The leaf powder was resuspended in 500 ml of 10 mM 
tris-Cl pH7.0 to which 10 mM beta-mercaptoethanol has 
been added. The Suspension was then homogenized in a 
Waring blender. The resulting extract was centrifuged at 
5,000 rpm for 30 minutes at 4 C. and the Supernatant was 
further clarified by filtering through three layers of cheese 
cloth. Plant extracts used for Studies on hydrolysis of endog 
enous polysaccharides as Sources of transgenic proteins 
were prepared using one leaf (medium to large) for each 
plant which was harvested and ground to a fine powder in 
liquid nitrogen. The ground leaves were resuspended in 2 
volumes of 100 mM sodium phosphate pH 7.0 with 10 mM 
beta-mercaptoethanol and the tissue was further homog 
enized in a Waring blender. The resulting extracts were then 
incubated at 80 C. to activate the recombinant alpha 
glucosidase and beta-glycosidase for 48 hours. After 
incubation, the extracts were clarified by centrifugation by 
12,500 rpm for 10 minutes 4 C. Glucose released by 
glycosyl hydrolase action on endogenous plant carbohy 
drates was measured using the Glucose Oxidase ASSay (Sigma). 
Example 7 
Detection of Recombinant Alpha-glucosidase and 
Beta-glycosidase Activity in Nicotiana tabacum and 
Determination of its Substrate Specificity 
ASSays of recombinant alpha-glucosidase from concen 
trated tobacco extract used by alpha-linked para 
nitrophenlglucoside (Sigma) or 4-methylumbelliferyl-C-D- 
glucoside (4-MUG) (Sigma) as Substrates at concentrations 
of 1 mM in 0.05M sodium acetate buffer at pH 4.5. Total 
protein was quantified using the Bradford protein assay kit 
from BioRad (Bradford, 1976). Extract was incubated one 
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hour at 85 C. and re-clarified to remove any endogenous 
tobacco alpha-glucosidase. Extract and Substrate were pre 
warmed for 10 minutes then combined in a reaction volume 
of 300 ul, layered with 150 ul mineral oil and incubated 3 
hours at 85 C. Aliquots of 25 ul were removed after Zero 
and three hours of incubation and transferred to Stop Solution 
consisting of 1 M Na2CO. The reaction product, 
4-methylumbelliferone, was detected on a DyNAQuant 200 
fluorometer. Each extract was assayed in duplicate. Routine 
assays of beta-glycosidase were performed as described by 
Haseltine, et al., 1999(a). 
Tobacco leaf extracts to be used for detection of glycosyl 
hydrolase antigens were concentrated 3-fold by (NH). SO 
precipitation. Westem blot analysis followed protocols from 
Sambrook, et al., 1989. Preparations were made 1x in 
SDS-PAGE sample buffer and 30 ug total protein per well 
was oaded on a 12% SDS polyacrylamide gel (8% stacking) 
and electrophoresed ccording to Haseltine, et al., 1999(b). 
Proteins (Amersham) were transferred to nitrocellulose and 
incubated. Chemiluminescent (colormetric) western blots 
were performed as described by Rolfsmeier, et al., 1998. The 
recombinant E coli extracts used as controls for the alpha 
glucosidase and the beta-glycosidase on Western blots were 
prepared as previously described (Haseltine, et al., 1999(b)). 
Concentrated plant protein extracts were diluted 1:10 in 10 
mM tris-Cl pH 7.0.50 ul of anti-malA antibodies were added 
to 200 ul of diluted extract and incubated for 2 hours at 4 
C. with gentle agitation. After incubation, an equivalent of 
350 lug of protein A was added and the mixture was 
incubated for 3 hours at 4 C. and the Supernatant was 
collected and assayed for alpha-glucosidase activity using 
the MUG assay. Blots were soaked with a chemiluminescent 
Substrate Solution (Amersham) and results visualized by 
autoradiography and quantified by densitometry. 
The substrate 4-MUG broke down at 85°C., pH 4.5, to 
form fluorescent product at about the same rate in the 
presence or absence of tobacco leaf extract made from plants 
transformed with the empty vector pPZP112. When 1 mM 
4-MUG was incubated with extract from a plant transformed 
with the malA gene, the rate of product formation was close 
to Six times the rate of product formation in the presence of 
extract made from empty vector control. Fluorescence due to 
endogenous compounds in tobacco extracts was unchanged 
for four hours at 85 C. 
Glucosyl hydrolase levels were determined in primary 
plant transformants using clarified leaf extracts incubated at 
80 C. Plants transformed with empty vector lacked detect 
able thermostable glycosyl hydrolase activity. Activity was 
measured on fully expanded leaves of plants that had grown 
in soil for 76 to 164 days. Levels of the beta-glycosidase in 
young primary transformants was determined in twenty 
three independent events. Enzyme levels in ten representa 
tive isolates ranged over 12-fold with maximum values of 29 
umoles PNP/min/mg of protein (FIG. 5B). Eight represen 
tative isolates of twenty-two independent events exhibited 
enzyme specificity over a 13-fold range with maximum 
values of 13 pmoles PNP/hr/mg protein (FIG. 5A). 
The protein identity of the thermostable glycosyl hydro 
lase activities was confirmed by Western blot analysis of 
plant extracts (FIG. 12). Western blot analysis of plant 
extracts derived from the T2 plant JJ-6, transformed with the 
lacS gene, detected a protein with an apparent mass of 60 
kDa (FIG. 12B, lane 1). No cross-reacting material was 
evident in extracts from a plant transformed with an empty 
vector (lane 2). Recombinant beta-glycosidase produced 
using a recombinant E. coli expression Strain (Sunna, 1997) 
was used as a positive control for these experiments. Deg 
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radation of this material is apparent and resulted from 
proteolysis during preparation of the E. coli extract. No 
croSS-reacting material was evident in whole cells extracts 
from E. coli lacking the lacS expression plasmid (lane 3). 
Similar results were obtained for plants transformed with the 
malA gene expression construct (FIG. 12A). Recombinant 
alpha-glucosidase protein produced using a recombinant E. 
coli expression Strain (Sunna, 1997) was used as a positive 
control (FIG. 12A, lane 1). A protein with an apparent mass 
of 80 kDa and identical to the positive control sample mass 
was detected in extracts of the T2 plant MI52E but not in 
extracts of the plant transformed with the empty vector 
(lanes 2 and 3, respectively). 
Precipitation of tobacco leaf proteins with (NH). SO 
achieved a 3-fold concentration of the recombinant alpha 
glucosidase with a recovery of 100%. Endogenous plant 
glycolytic activities were eliminated prior to malA assays by 
heat inactivation (1 hr., 55° C). Background due to endog 
enous glucose was removed by dialysis. Initial attempts to 
assay concentrated extract from tobacco transformed with 
malA vector or empty vector, with or without 5% starch as 
Substrate, failed to demonstrate activity in the malA tobacco 
extract due to a very high background in the presence of the 
Starch. In an attempt to remove this background, concen 
trated empty vector control eXtract was pre-incubated for 
one hour at 85°C., clarified by microcentrifugation and then 
incubated for 0 or 14 hour at 85 C. in the presence or 
absence of 5% starch. Without preincubation, background in 
the presence of Starch was very high, at both 0 and at 14 
hours, corresponding to 17.8 to 19.2 micrograms of glucose 
per 100 microliters of assay. Background in the absence of 
Starch was much lower, but apparently more time 
dependent, rising from 0.9 to 1.6 micrograms of glucose per 
100 microliters in 14 hours (FIG. 7). When the extract was 
pre-heated before assay, the background in the absence of 
Starch was unchanged, but the background in the presence of 
Starch was then at the same level as the background in the 
absence of starch without pre-heating (FIG. 7). Based on 
these results, the very high background appears to have been 
due to one or more endogenous tobacco enzymes active at 
room temperature, and acting on added Starch during the 
interval between combining the reaction components and 
transferring reaction mixes from 250 to 85 C. The back 
ground in the absence of added Starch might have been due 
to nonenzymatic degradation of an endogenous glucose 
polymer, or due to formation of compounds that interfere 
with the glucose oxidase assay. 
AS with the empty vector extract, the background in the 
absence of Starch was lower than the background in the 
presence of added Starch, rising from 1.3 to 5.3 micrograms 
of glucose per 100 microliters in 16 hours, and was not 
affected by pre-treatment of one hour at 85°C. (FIG. 7). The 
background in the presence of added Starch was greatly 
reduced by the one-hour pre-treatment, but was dependent 
on incubation time at 85 C., and was still substantially 
greater than the background in the absence of added Starch, 
rising from 2.0 to 10.2 micrograms of glucose per 100 
microliters in 16 hours. The net rate of glucose formation, 
which is believed to represent the conversion of added starch 
to glucose by the recombinant alpha-glucosidase, was 0.42 
micrograms per hour (FIG. 7). 
Since significantly greater amounts of plant extract were 
required to detect the alpha-glucosidase compared to the 
beta-glycosidase, additional experiments using protein 
immunoprecipitation were conducted to further confirm 
alpha-glucosidase production (FIG. 12C). A sample of T2 
plant MI52E extract was treated with the anti-alpha 
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glucosidase antibody and antibody-antigen complexes were 
removed by StaphylococcuS protein-A treatment. The 
residual activity remaining in the treated Samples was then 
determined by enzyme assay. Additional Samples of T2 plant 
MI52E extract treated with Staphylococcus protein A alone 
or with no treatment were also analyzed for residual alpha 
glucosidase activity. Nearly complete removal of alpha 
glucosidase was evident in Samples treated with the anti 
alpha-glucosidase antibodies but not in untreated Samples or 
in samples treated only with protein A. The results verify 
production of the thermostable glycosyl hydrolases in 
tobacco leaves. 
For measurements of glycosyl hydrolase activities on 
glucose polymers. An equal volume of -20° C. acetone was 
added to extract, followed by storage at -20°C. for one hour 
and centrifugation for 30 minutes at 10,000xg (GSA rotor, 
rp.m.). Pellets were lyophilized, then resuspended with 
about 1/100 the original volume of 10 mM tris HCl pH 7 and 
clarified by microcentrifugation. After incubating one hour 
at 85 C. and reclarifying, extracts were lyophilized to 
remove free glucose and Small Solutes that could interfere 
with the glucose oxidase assay. ASSays of alpha-glucosidase 
on starch used soluble potato starch (from Fluka) at 5% 
(w/v) in 0.05 M Sodium acetate buffer, pH 4.5. Aliquots of 
100 ul were removed at four hour intervals and glucose was 
detected with a glucose oxidase glucose detection kit from 
Sigma. 
The recombinant alpha-glucosidase from tobacco was 
active on maltose and a number of other O-(1->4) linked 
glucose polymers, as shown in Table 1. This demonstrates 
that the recombinant hydrolases of the present invention are 
useful for release of other Sugars in addition to glucose. 
TABLE 1. 
Substrate Specificity of the 
Sulfolobus solfataricus C. glucosidase 
Specific Activity (umoles 
Substrate glucose/min/mg) 
Maltose 3.32 - 0.46 
Maltotriose 1.17 O.26 
Maltotetrose 1.91 - 0.61 
Maltoheptose 148 OOO 
Sucrose 1.29 O.O3 
Dextrin (1% w/v) 0.85 + 0.04 
Starch (1% w/v) 4.75 - O.S 
Starch (5% w/v) 8.67 + O.O 
Glycogen (1% w/v) O.52 O.O7 
Glycogen (5% w/v) 3.75 O.3 
Substrate concentrations were 10 mM except dextrin, starch and glycogen 
which were performed at the concentrations listed. Assays were performed 
30 minutes at 80 C. 
Indicates the assay was performed with the recombinant enzyme. 
Example 8 
Expression and Accumulation of Recombinant 
Glycosyl Hydrolases by Second Generation 
Tobacco Plants 
T2 were obtained by Screening Seed for kanamycin resis 
tant germination. Single copy transgene insertions were 
identified as yielding kanamycin resistance Segregation fre 
quencies of 3:1 in T3 Seed. T2 plants harboring Single 
insertions from Several independent lines were used for 
detailed experiments. Of the 17 NPT II-positive tobacco 
plants, nine had Sufficient levels of the alpha-glucosidase to 
be detected with reasonable certainty. Recovery of tobacco 
plants producing the beta-glycosidase occurred at frequen 
cies Similar to those of the alpha-glucosidase. 
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Analysis of enzyme levels in fully expanded leaf tissue 
Samples from identical T2 plants collected over time indi 
cated that the glycosyl hydrolase activities increased as the 
plants matured (FIG. 11). Total protein was measured on 
both a fresh weight and leaf area basis. In contrast to the 
expected pattern observed with most transgenic proteins 
(Sunna, 1997), levels of the alpha-glucosidase were low in 
younger plants and reached appreciable levels as plants aged 
and following flower formation (FIG. 11B). Total protein 
levels in contrast were most elevated in younger plants and 
decreased significantly as the plants aged. A similar novel 
pattern of accumulation was observed for transgenic plants 
producing the beta-glycosidase (FIG. 11A). 
Example 9 
Stability of Recombinant Glycosyl Hydrolases in 
Preserved Plant Tissue 
It has been determined that glycosyl hydrolaseS retain 
Significant activity in fully mature and preserved leaf tissue. 
Glycosyl hydrolase Specific activities in plant tissues were 
compared, after freezing or drying, to levels in fresh tissue 
Samples (Table 2). Significant beta-glycosidase activity was 
retained in leaves harvested and held at -80 C. for 5 days. 
In contrast, the alpha-glucosidase activity was over two 
times more stable when frozen and 17 times more stable 
when dried, as compared to fresh tissues. 
The retention of transgenic glycosyl hydrolase activities 
in preserved plant tissues confirms that the plant tissue can 
be stored for later use as a Source of hydrolase activity. This 
means that crops traditionally used for forage would be 
useful and appropriate hosts Since they are left in the field 
until after winter. 
TABLE 2 
Stability of Recombinant Glycosyl Hydrolases 
in Preserved Plant Tissue 
Beta-glycosidase Alpha-glucosidase 
Condition (umoles PNP/min/mg) (umoles PNP/hr/mg) 
Frozen 67 3.6 
Dried 31 27 
Fresh 62 1.6 
Example 10 
Autodigestion of Plant Substrates by Thermostable 
Enzymes 
Conversion of plant polysaccharide into free Sugar is 
conventionally done by addition of purified or Semipurified 
hydrolytic enzymes. AS an example of the use of endog 
enous thermostable enzymes for plant bioprocessing, the 
ability of plant protein extracts to hydrolyze polysaccharides 
such as starch was demonstrated (FIGS. 7A and 7B). Protein 
extracts of the alpha-glucosidase transgenic plant MI52E, 
were prepared and combined with soluble starch. Plant 
leaves were harvested in the late afternoon, ground in liquid 
nitrogen with a mortar and pestle in 100 mM phosphate 
buffer at pH 7.0. Upon incubation at 80 C., glucose was 
released in a manner which was collinear with time. No 
Significant glucose was detected in reactions containing 
protein extracts from plants transformed with empty vector 
and added Starch or in reactions containing Starch alone. The 
rate of appearance of glucose was 0.11 lug/hr for alpha 
glucosidase and 0.15 lug/hr for beta-glucosidase. These 
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results demonstrated that glycosyl hydrolase in plant protein 
extracts could depolymerize added exogenous Soluble 
Starch. 
To demonstrate the use of endogenous plant polysaccha 
rides as Substrates for the transgenic glycosyl hydrolases, 
transgenic tobacco protein extracts were combined with 
tobacco extracts processed to enrich for polysaccharide 
content (Sunna, 1997). Levels of liberated glucose were 
determined as a function of incubation time at 80 C. After 
an initial lag of 28 hr., levels of glucose began to increase in 
extracts containing either the alpha-glucosidase or the beta 
glycosidase. In contrast, glucose levels did not increase in 
reactions containing the polysaccharide enriched extracts 
and a protein extract from plants transformed with an empty 
vector. Glucose release continued for the duration of the 
experiment which was terminated after 160 hr. These results 
demonstrate that transgenic levels of the glycosylhydrolases 
are Sufficient to catalyze hydrolysis of endogenous polysac 
charide using extracts Separately enriched for proteins and 
Substrate. 
Direct conversion of plant tissue into Sugar without resort 
to extract fractionation (autodigestion) was examined by 
high temperature incubation of crude unfractionated trans 
genic plant extracts. To better assess the amount of Sugar 
released by autodigestion of transgenic plant tissue, the 
resulting preparations were used as growth media for the 
cultivation of bacteria. Crude extracts of plants transformed 
with malA and lacs genes were prepared, incubated at 80 
C., then clarified. E. coli K12 cells (10) were washed and 
inoculated into flaskS containing the clarified extracts. The 
flasks were incubated overnight at 37 C. Control flasks 
were prepared with extract from plants transformed with the 
empty vector. Both glycosyl hydrolase plant extracts Sup 
ported high cell density growth of E. coli K12 while a plant 
transformed with an empty vector did not. The ratio of 
microbial biomass produced from transgenic glycosyl 
hydrolase plants was examined by determining the microbial 
growth yield on a per Volume basis of incubated plant crude 
extract. When beta-glycosidase and alpha-glucosidase crude 
extracts we recombined microbial biomass yields were 
proportionally greater. 
While the invention has been disclosed in this patent 
application by reference to the details of preferred embodi 
ments of the invention, it is to be understood, that the 
disclosure is intended in an illustrative rather than in a 
limiting Sense, as it is contemplated that modifications will 
readily occur to those skilled in the art, within the spirit of 
the invention and the Scope of the appended claims. 
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SEQUENCE LISTING 
<160> NUMBER OF SEQ ID NOS: 4 
<210> SEQ ID NO 1 
&2 11s LENGTH 228O 
&212> TYPE DNA 
<213> ORGANISM: Sulfolobus solfataricus 
&22O > FEATURE 
<221 NAME/KEY: CDS 
<222> LOCATION: (172). . (2250) 
<400 SEQUENCE: 1 
taggaattat cqaattcaac gotttitccaa taaatactaa ttggitttaaa cittaacgtta 60 
tgtagittagt tattgtcata atcc.gaaaaa aggataacaa totagttgtt taggataaac 120 
tagataaagg aagctittata ttittgaagag aattgtatac ggtgataag g g at g cag 177 
Met Glin 
1 
aca ata aaa at a tac gag aac aaa goc gtt tac aaa gta gtt ata gga 225 
Thir Ile Lys Ile Tyr Glu Asn Lys Gly Val Tyr Lys Val Val Ile Gly 
5 10 15 
gaa cca titt coc coc at a gaa titc cca citt gag caa aag ata toa tog 273 
Glu Pro Phe Pro Pro Ile Glu Phe Pro Leu Glu Gln Lys Ile Ser Ser 
2O 25 30 
aat aaa tot tta to a gag ttg ggit tta aca at a gtt caa caa got aac 321 
Asn Lys Ser Lieu Ser Glu Lieu Gly Lieu. Thir Ile Val Glin Glin Gly Asn 
35 40 45 5 O 
aag gtt att gtc gag aaa to a ttg gat ttg aaa gag cac attata gga 369 
Lys Val Ile Val Glu Lys Ser Lieu. Asp Lieu Lys Glu His Ile Ile Gly 
55 60 65 
ttg gga gag aag gC g titt gag titg gat aga aag agg aaa agg tat gtg 417 
Leu Gly Glu Lys Ala Phe Glu Lieu. Asp Arg Lys Arg Lys Arg Tyr Val 
70 75 8O 
atg tat aac gtt gac got ggg gct tat aag aaa tat caa gat coa citt 465 
Met Tyr Asn Val Asp Ala Gly Ala Tyr Lys Lys Tyr Glin Asp Pro Leu 
85 90 95 
tac gtt agt at a coc tta titt ata to a gtg aaa gac ggc gtt gca act 513 
Tyr Val Ser Ile Pro Leu Phe Ile Ser Val Lys Asp Gly Val Ala Thr 
1 OO 105 110 
ggit tac titc titc aac to a gCt tot aaa gtg atc titc gac gtg gga citt 5 61 
Gly Tyr Phe Phe Asin Ser Ala Ser Lys Val Ile Phe Asp Val Gly Leu 
115 120 125 130 
gag gaa tac gat aaa gta att gtt aca att coa gag gac to a gta gag 609 
Glu Glu Tyr Asp Llys Val Ile Val Thr Ile Pro Glu Asp Ser Val Glu 
135 14 O 145 
ttt tac gtg att gala ggg cca aga att gag gac gtt ct a gag aaa tac 657 
Phe Tyr Val Ile Glu Gly Pro Arg Ile Glu Asp Val Leu Glu Lys Tyr 
15 O 155 160 
acg gag citt acc gga aaa cct titc cita cct coc at g togg gct titc ggit 705 
Thr Glu Leu Thr Gly Lys Pro Phe Leu Pro Pro Met Trp Ala Phe Gly 
1.65 170 175 
tac 
tta 
Teu 
195 
tta 
Teu 
tat 
aac 
Asn 
aat 
Asn 
agt 
Ser 
275 
cca 
Pro 
to c 
Ser 
gaa 
Glu 
tog 
Ser 
gat 
Asp 
355 
gtt 
Wall 
titt 
Phe 
tat 
cct 
Pro 
tog 
Ser 
435 
ggC 
Gly 
tat 
act 
Thr 
atg 
Met 
18O 
gta 
Wall 
gat 
Asp 
agg 
Arg 
gtt 
Wall 
tat 
Tyr 
260 
ggit 
Gly 
gac 
Asp 
gaa 
Glu 
cca 
Pro 
tta 
Telu 
34 O 
a.a. C. 
Asn 
aga 
Arg 
agg 
Arg 
gcc 
Ala 
toa 
Ser 
420 
att 
Ile 
agg 
Arg 
tat 
gat 
Asp 
ata 
Ile 
gat 
Asp 
ata 
Ile 
titc. 
Phe 
aag 
Lys 
245 
toa 
Ser 
gaa 
Glu 
titc. 
Phe 
tgg 
Trp 
act 
Thr 
325 
cc c 
Pro 
gta 
Wall 
aat 
Asn 
aCa 
Thr 
gga 
Gly 
405 
tgg 
Trp 
tot 
Ser 
a.a. C. 
Asn 
gct 
Ala 
ggit 
Gly 
485 
toa 
Ser 
ata 
Ile 
cac 
His 
cca 
230 
cita 
Lel 
cca 
cita 
Lel 
Phe 
citt 
Lel 
310 
gac 
Asp 
gta 
Wall 
gtt 
Wall 
gct 
Ala 
agc 
Ser 
390 
ata 
Ile 
gat 
Asp 
ggit 
Gly 
titc. 
Phe 
tta 
Telu 
470 
ata 
Ile 
cgc 
Arg 
atg 
Met 
tac 
Tyr 
215 
gaa 
Glu 
att 
Ile 
titt 
Phe 
titc. 
Phe 
agg 
Arg 
295 
toa 
Ser 
titc. 
Phe 
cag 
Glin 
cac 
His 
tat 
Tyr 
375 
cat 
His 
Cala 
Glin 
gat 
Asp 
gta 
Wall 
gCg 
Ala 
455 
gcc 
Ala 
gat 
Asp 
tac 
Cala 
Glin 
200 
atg 
Met 
cct 
Pro 
a Ca 
Thr 
citt 
Teu 
gta 
Wall 
280 
gag 
Glu 
Cala 
Glin 
tct 
Ser 
titc. 
Phe 
tac 
Tyr 
360 
cct 
Pro 
agg 
Arg 
aga 
Arg 
Teu 
cca 
Pro 
4 40 
gaa 
Glu 
ttg 
Teu 
acg 
Thr 
35 
tct 
Ser 
185 
aag 
Lys 
gac 
Asp 
a.a.a. 
alta 
Ile 
to c 
Ser 
265 
ggit 
Gly 
gat 
Asp 
gga 
Gly 
agg 
Arg 
aga 
Arg 
345 
Teu 
tta 
Teu 
aat 
Asn 
tac 
aag 
Lys 
4.25 
titt 
Phe 
att 
Ile 
titc. 
Phe 
gaa 
Glu 
tac 
gag 
Glu 
to c 
Ser 
aag 
Lys 
gtt 
Wall 
25 O 
gga 
Gly 
a.a.a. 
act 
Thr 
gtt 
Wall 
gct 
Ala 
330 
gat 
Asp 
agg 
Arg 
tat 
gaa 
Glu 
gca 
Ala 
410 
citt 
Telu 
gta 
Wall 
gac 
Asp 
titc. 
Phe 
cca 
Pro 
490 
tac 
ggit 
Gly 
tat 
cita 
Telu 
235 
gac 
Asp 
atg 
Met 
atg 
Met 
aga 
Arg 
gat 
Asp 
315 
att 
Ile 
gat 
Asp 
gga 
Gly 
gag 
Glu 
ata 
Ile 
395 
titc. 
Phe 
Cala 
Glin 
ggit 
Gly 
a.a. C. 
Asn 
cc c 
Pro 
475 
gtt 
Wall 
cc c 
Pro 
titt 
Phe 
aag 
Lys 
220 
att 
Ile 
cac 
His 
gga 
Gly 
tgg 
Trp 
gaa 
Glu 
3OO 
ggit 
Gly 
gag 
Glu 
aga 
Arg 
aag 
Lys 
gct 
Ala 
38O 
titt 
Phe 
atc 
Ile 
cita 
Telu 
Cys 
tot 
Ser 
460 
titc. 
Phe 
titc. 
Phe 
cag 
Glin 
aga 
Arg 
2O5 
tta 
Teu 
gac 
Asp 
gga 
Gly 
a.a.a. 
Lys 
cct 
Pro 
285 
tgg 
Trp 
att 
Ile 
atc 
Ile 
citt 
Teu 
agg 
Arg 
365 
atg 
Met 
atc 
Ile 
Trp 
Cala 
Glin 
gat 
Asp 
4 45 
atg 
Met 
tat 
citg 
Teu 
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gat 
Asp 
190 
gta 
Wall 
titt 
Phe 
gaa 
Glu 
alta 
Ile 
titc. 
Phe 
270 
ggit 
Gly 
tgg 
Trp 
tgg 
Trp 
aga 
Arg 
gtt 
Wall 
350 
gtt 
Wall 
gca 
Ala 
Teu 
act 
Thr 
Teu 
430 
alta 
Ile 
gat 
Asp 
agg 
Arg 
cca 
Pro 
aag 
Lys 
gct 
Ala 
a Ca 
Thr 
tta 
Teu 
agg 
Arg 
255 
act 
Thr 
gct 
Ala 
cita 
Teu 
gac 
Asp 
335 
acc 
Thr 
a.a.a. 
acg 
Thr 
agt 
Ser 
ggit 
Gly 
415 
gtt 
Wall 
ggit 
Gly 
tta 
Teu 
toa 
Ser 
gat 
Asp 
495 
gtt 
Wall 
gga 
Gly 
tgg 
Trp 
cac 
His 
24 O 
gtt 
Wall 
gag 
Glu 
act 
Thr 
ggg 
Gly 
gac 
Asp 
320 
gtt 
Wall 
act 
Thr 
cac 
His 
titt 
Phe 
aga 
Arg 
400 
gat 
Asp 
citc. 
Teu 
gga 
Gly 
tta 
Teu 
cac 
His 
480 
tac 
Tyr 
gtt 
Wall 
gta 
Wall 
cat 
His 
225 
aag 
Lys 
gat 
Asp 
att 
Ile 
gtc 
Wall 
tta 
Telu 
305 
atg 
Met 
tta 
Leu 
titt 
Phe 
gaa 
Glu 
aag 
Lys 
385 
gcc 
Ala 
aat 
Asn 
ggC 
Gly 
titt 
Phe 
gtc 
Wall 
465 
aag 
Lys 
tat 
Tyr 
gag 
Glu 
titc. 
Phe 
210 
cct 
Pro 
aga 
Arg 
cag 
Glin 
gaa 
Glu 
tat 
Tyr 
290 
atc 
Ile 
aat 
Asn 
tot 
Ser 
cca 
Pro 
a.a.a. 
Lys 
370 
ggg 
Gly 
ggit 
Gly 
acc 
Thr 
tta 
Telu 
Cala 
Glin 
450 
a.a.a. 
Lys 
gca 
Ala 
aag 
Lys 
75.3 
801 
849 
897 
945 
993 
O 41 
O89 
137 
185 
233 
281 
329 
377 
425 
473 
521 
569 
617 
665 
36 
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-continued 
gag aaa gta aag gaa atc gtg gag titg agg tat aag titc tta coc tat 713 
Glu Lys Wall Lys Glu Ile Val Glu Lieu Arg Tyr Lys Phe Leu Pro Tyr 
5 OO 505 510 
att tat to c tta gct tta gag got agt gag aag gga cat cog gta att 761 
Ile Tyr Ser Lieu Ala Leu Glu Ala Ser Glu Lys Gly His Pro Val Ile 
515 52O 525 530 
aga cot cita ttt tac gaa titc cag gat gat gac gac atg tat aga ata 809 
Arg Pro Leu Phe Tyr Glu Phe Glin Asp Asp Asp Asp Met Tyr Arg Ile 
535 540 545 
gala gac gag tat atg gtt got aag tat ttg citt tac got coa att gta 857 
Glu Asp Glu Tyr Met Val Gly Lys Tyr Leu Leu Tyr Ala Pro Ile Val 
550 555 560 
agt aaa gag gag agt agg tta gta aca tta cott aga. g.gt aag togg tac 905 
Ser Lys Glu Glu Ser Arg Lieu Val Thr Lieu Pro Arg Gly Lys Trp Tyr 
565 570 575 
aat tac tog aat ggc gag ata ata aac ggit aag agt gtt gtt aag tot 95.3 
Asn Tyr Trp Asn Gly Glu Ile Ile Asn Gly Lys Ser Val Val Lys Ser 
58O 585 590 
act cat gag ttg cca att tac titg aga. gala gga toa ata atc cc g ttg 2001 
Thr His Glu Leu Pro Ile Tyr Leu Arg Glu Gly Ser Ile Ile Pro Leu 
595 600 605 610 
gag ggit gac gag tta ata gtt tac ggit gag acc tog titc aag cqt tac 2O49 
Glu Gly Asp Glu Lieu. Ile Val Tyr Gly Glu Thir Ser Phe Lys Arg Tyr 
615 62O 625 
gat aat gct gala att acc toc to a agt aat gala att aag titt to a agg 2097 
Asp Asn Ala Glu Ile Thr Ser Ser Ser Asn. Glu Ile Lys Phe Ser Arg 
630 635 640 
gag att tat gta tot aag cita act atc aca toa gag aaa cca gtg agc 2145 
Glu Ile Tyr Val Ser Lys Leu Thir Ile Thr Ser Glu Lys Pro Val Ser 
645 650 655 
aag ata at a gtt gac gat agt aag gala att caa gta gag aag aca atg 21.93 
Lys Ile Ile Val Asp Asp Ser Lys Glu Ile Glin Val Glu Lys Thr Met 
660 665 670 
caa aac act tac gtt gct aag att aat caa aaa att agg gga aag att 2241 
Glin Asn. Thir Tyr Val Ala Lys Ile Asn Gln Lys Ile Arg Gly Lys Ile 
675 680 685 690 
aac cta gag tagttttittc acgtacticca agg acttaac 228O 
Asn Lieu. Glu 
<210> SEQ ID NO 2 
&2 11s LENGTH 693 
&212> TYPE PRT 
<213> ORGANISM: Sulfolobus solfataricus 
<400 SEQUENCE: 2 
Met Glin Thr Ile Lys Ile Tyr Glu Asn Lys Gly Val Tyr Lys Val Val 
1 5 10 15 
Ile Gly Glu Pro Phe Pro Pro Ile Glu Phe Pro Leu Glu Gln Lys Ile 
2O 25 30 
Ser Ser Asn Lys Ser Leu Ser Glu Lieu Gly Lieu. Thir Ile Val Glin Glin 
35 40 45 
Gly Asn Lys Val Ile Val Glu Lys Ser Lieu. Asp Leu Lys Glu His Ile 
5 O 55 60 
Ile Gly Lieu Gly Glu Lys Ala Phe Glu Lieu. Asp Arg Lys Arg Lys Arg 
65 70 75 8O 
Tyr Val Met Tyr Asn. Wall Asp Ala Gly Ala Tyr Lys Lys Tyr Glin Asp 
85 90 95 
Pro Leu Tyr Val Ser Ile Pro Leu Phe Ile Ser Val Lys Asp Gly Val 
38 
Ala 
Gly 
Wall 
145 
Phe 
Wall 
Wall 
His 
225 
Asp 
Ile 
Wall 
Teu 
305 
Met 
Teu 
Phe 
Glu 
Lys 
385 
Ala 
Asn 
Gly 
Phe 
Wall 
465 
Pro 
Thr 
Telu 
130 
Glu 
Gly 
Glu 
Phe 
210 
Pro 
Arg 
Glin 
Glu 
Tyr 
29 O 
Ile 
Asn 
Ser 
Pro 
Lys 
370 
Gly 
Gly 
Thr 
Telu 
Glin 
450 
Gly 
115 
Glu 
Phe 
Thr 
Telu 
195 
Telu 
Asn 
Asn 
Ser 
275 
Pro 
Ser 
Glu 
Ser 
Asp 
355 
Wall 
Phe 
Pro 
Ser 
435 
Gly 
Thr 
Glu 
Ile 
515 
100 
Glu 
Met 
Wall 
Asp 
Arg 
Wall 
Tyr 
260 
Gly 
Asp 
Glu 
Pro 
Telu 
340 
Asn 
Arg 
Arg 
Ala 
Ser 
420 
Ile 
Arg 
Asp 
Lys 
5 OO 
Phe 
Wall 
Teu 
1.65 
Ile 
Asp 
Ile 
Phe 
Lys 
245 
Ser 
Glu 
Phe 
Trp 
Thr 
325 
Pro 
Wall 
Asn 
Thr 
Gly 
405 
Trp 
Ser 
Asn 
Ala 
Gly 
485 
Wall 
Ser 
Phe 
Asp 
Ile 
15 O 
Thr 
Ser 
Ile 
His 
Pro 
230 
Lel 
Lel 
Phe 
Lel 
310 
Asp 
Wall 
Wall 
Ala 
Ser 
390 
Ile 
Asp 
Gly 
Phe 
Teu 
470 
Ile 
Teu 
39 
Asn 
Lys 
135 
Glu 
Gly 
Arg 
Met 
Tyr 
215 
Glu 
Ile 
Phe 
Phe 
Arg 
295 
Ser 
Phe 
Glin 
His 
Tyr 
375 
His 
Glin 
Asp 
Wall 
Ala 
455 
Ala 
Asp 
Glu 
Ala 
Ser 
120 
Wall 
Gly 
Glin 
200 
Met 
Pro 
Thr 
Telu 
Wall 
280 
Glu 
Glin 
Ser 
Phe 
Tyr 
360 
Pro 
Arg 
Arg 
Telu 
Pro 
4 40 
Glu 
Telu 
Thr 
Ile 
Telu 
52O 
105 
Ala 
Ile 
Pro 
Pro 
Ser 
185 
Ile 
Ser 
265 
Gly 
Asp 
Gly 
Arg 
Arg 
345 
Telu 
Telu 
Asn 
Lys 
425 
Phe 
Ile 
Phe 
Glu 
Wall 
505 
Glu 
Ser 
Wall 
Arg 
Phe 
170 
Glu 
Ser 
Wall 
250 
Gly 
Thr 
Wall 
Ala 
330 
Asp 
Arg 
Glu 
Ala 
410 
Telu 
Wall 
Asp 
Phe 
Pro 
490 
Glu 
Ala 
Thr 
Ile 
155 
Teu 
Teu 
235 
Asp 
Met 
Met 
Arg 
Asp 
315 
Ile 
Asp 
Gly 
Glu 
Ile 
395 
Phe 
Glin 
Gly 
Asn 
Pro 
475 
Wall 
Teu 
Ser 
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Wall 
Ile 
1 4 0 
Glu 
Pro 
Pro 
Phe 
Lys 
220 
Ile 
His 
Gly 
Trp 
Glu 
Gly 
Glu 
Arg 
Ala 
38O 
Phe 
Ile 
Teu 
Ser 
460 
Phe 
Phe 
Arg 
Glu 
Ile 
125 
Pro 
Asp 
Pro 
Glin 
Arg 
Teu 
Asp 
Gly 
Pro 
285 
Trp 
Ile 
Ile 
Teu 
Arg 
365 
Met 
Ile 
Trp 
Glin 
Asp 
4 45 
Met 
Teu 
Lys 
525 
110 
Phe 
Glu 
Wall 
Met 
Asp 
190 
Wall 
Phe 
Glu 
Ile 
Phe 
27 O 
Trp 
Trp 
Arg 
Wall 
350 
Wall 
Ala 
Teu 
Thr 
Teu 
430 
Ile 
Asp 
Arg 
Pro 
Tys 
510 
Asp 
Telu 
Trp 
175 
Lys 
Ala 
Thr 
Telu 
Arg 
255 
Cys 
Thr 
Ala 
Telu 
Asp 
335 
Thr 
Lys 
Thr 
Ser 
Gly 
415 
Wall 
Gly 
Telu 
Ser 
Asp 
495 
Phe 
His 
Wall 
Ser 
Glu 
160 
Ala 
Wall 
Gly 
Trp 
His 
240 
Wall 
Glu 
Thr 
Gly 
Asp 
320 
Wall 
Thr 
His 
Phe 
Arg 
400 
Asp 
Telu 
Gly 
Telu 
His 
480 
Tyr 
Telu 
Pro 
40 
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-continued 
Wall Ile 
530 
Arg Pro Leu Phe Tyr Glu Phe Glin 
535 
Asp 
540 
Arg Ile Glu Glu Met Wall Teu Teu 
545 
Asp Tyr 
550 
Gly Lys Tyr 
555 
Ile Wall Glu 
565 
Glu Wall 
570 
Ser Ser Arg Lieu Thir Leu Pro 
Glu Ile 
585 
Trp Tyr Asn Tyr Asn Ile Asn Trp Gly Gly Lys 
Glu Ile 
600 
Thr His Leu Pro Telu Glu 
595 
Ser Tyr Arg Gly 
605 
Glu Glu Ile Wall Glu Teu Thr 
615 
Telu 
610 
Pro Gly Asp Gly 
Ala Glu 
630 
Ile Thr Ser Asn. Glu 
635 
Arg Asn Ser Ser 
625 
Tyr Asp 
Glu Ile Wall Thr 
650 
Ser Tyr Ser Telu Ile Thir Ser 
645 
Wall Ile 
660 
Ile Wall Ser Glu Ile Glin 
665 
Ser Lys Asp Asp 
Thr Met Glin 
675 
Thr Wall Ala 
680 
Asn Lys Ile Asn Gln Lys 
685 
Ile 
69 O. 
Asn Lieu. Glu 
SEQ ID NO 3 
LENGTH 19 
TYPE PRT 
ORGANISM: Sulfolobus solfataricus 
<400 SEQUENCE: 3 
Asp Asp Asp Met 
Tyr 
Ser 
59 O 
Ser 
Ser 
Ile 
Glu 
Wall 
670 
Ile 
Ala Pro 
560 
Gly 
575 
Lys 
Wal Wall 
Ile Ile 
Phe 
Phe 
640 
Lys Pro 
655 
Glu 
Arg Gly 
Met Glin Thr Ile Lys Ile Tyr Glu Asn Leu Gly Val Tyr Leu Trp Ile 
1 5 10 
Gly Glu Pro 
SEQ ID NO 4 
LENGTH 10 
TYPE PRT 
ORGANISM: Sulfolobus solfataricus 
<400 SEQUENCE: 4 
Val Gly Lys Tyr Lieu Lleu Tyr Ala Pro Ile 
1 5 10 
I claim: 
1. A method for converting plant Substrate, comprising 
heating Said Substrate in the presence of recombinant hyper 
thermophilic glycosyl hydrolase, wherein Said Substrate 
comprises extract of plant transformed with Said recombi 
nant hyperthermophilic glycosyl hydrolase, and wherein the 
glycosyl hydrolase is localized with the Substrate in tissue of 
the plant. 
2. The method of claim 1, wherein said plant substrate 
further comprises a plant extract enriched for Said Substrate 
COntent. 
3. The method of claim 1, wherein said hyperthermophilic 
glycosyl hydrolase is from Sulfolobus species. 
4. The method of claim3 wherein said Sulfolobus species 
is Selected from the group consisting of S. SolfataricuS 98/2, 
S. Shibatae, S. acidocaldarius, and S. Solfataricus P2. 
55 
60 
65 
15 
5. The method of claim 1, wherein said hyperthermophilic 
glycosyl hydrolase is Selected from the group consisting of 
hyperthermophilic alpha-glucosidase, hyperthermophilic 
beta-glycosidase and combinations thereof. 
6. The method of claim 5, wherein said hyperthermophilic 
glycosyl hydrolase is hyperthermophilic alpha-glucosidase. 
7. The method of claim 5, wherein said hyperthermophilic 
glycosyl hydrolase is hyperthermophilic beta-glycosidase. 
8. The method of claim 1 wherein said plant substrate 
comprises polysaccharide. 
9. The method of claim 1, wherein said Substrate is heated 
at a temperature of between about 65 C. and about 85 C. 
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